10-Q
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
|
|
|
þ |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2009
or
|
|
|
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File Number 1-584
FERRO CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
Ohio
|
|
34-0217820 |
(State of Corporation)
|
|
(IRS Employer Identification No.) |
|
|
|
1000 Lakeside Avenue |
|
|
Cleveland, OH
|
|
44114 |
(Address of Principal executive offices)
|
|
(Zip Code) |
216-641-8580
(Telephone Number)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. YES þ NO o
Indicate by check mark whether the registrant has submitted electronically and posted on its
corporate Web site, if any, every Interactive Data File required to be submitted and posted
pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months
(or for such shorter period that the registrant was required to submit and post such files).
YES o NO o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated
filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
(Check one):
|
|
|
|
|
|
|
Large accelerated filer þ
|
|
Accelerated filer o
|
|
Non-accelerated filer o
|
|
Smaller reporting company o |
|
|
|
|
(Do not check if a smaller reporting company) |
|
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of
the Act). YES o NO þ
At September 30, 2009, there were 44,929,989 shares of Ferro Common Stock, par value $1.00,
outstanding.
PART I FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)
Ferro Corporation and Consolidated Subsidiaries
Condensed Consolidated Statements of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
Nine months ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands, |
|
|
|
except per share amounts) |
|
Net sales |
|
$ |
442,089 |
|
|
$ |
590,150 |
|
|
$ |
1,199,175 |
|
|
$ |
1,812,964 |
|
Cost of sales |
|
|
348,920 |
|
|
|
479,807 |
|
|
|
985,531 |
|
|
|
1,474,382 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
93,169 |
|
|
|
110,343 |
|
|
|
213,644 |
|
|
|
338,582 |
|
Selling, general and administrative expenses |
|
|
65,918 |
|
|
|
76,943 |
|
|
|
196,526 |
|
|
|
234,243 |
|
Impairment charges |
|
|
8,225 |
|
|
|
|
|
|
|
8,225 |
|
|
|
|
|
Restructuring charges |
|
|
2,842 |
|
|
|
9,042 |
|
|
|
3,931 |
|
|
|
22,280 |
|
Other expense (income): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
17,891 |
|
|
|
12,424 |
|
|
|
46,255 |
|
|
|
38,747 |
|
Interest earned |
|
|
(216 |
) |
|
|
(213 |
) |
|
|
(689 |
) |
|
|
(484 |
) |
Loss on extinguishment of debt |
|
|
|
|
|
|
5,531 |
|
|
|
|
|
|
|
5,531 |
|
Foreign currency losses, net |
|
|
104 |
|
|
|
1,647 |
|
|
|
3,033 |
|
|
|
756 |
|
Miscellaneous (income) expense, net |
|
|
(655 |
) |
|
|
237 |
|
|
|
199 |
|
|
|
3,231 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income before income taxes |
|
|
(940 |
) |
|
|
4,732 |
|
|
|
(43,836 |
) |
|
|
34,278 |
|
Income tax (benefit) expense |
|
|
(3,749 |
) |
|
|
876 |
|
|
|
(15,844 |
) |
|
|
14,290 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations |
|
|
2,809 |
|
|
|
3,856 |
|
|
|
(27,992 |
) |
|
|
19,988 |
|
Income from discontinued operations, net of income taxes |
|
|
|
|
|
|
1,259 |
|
|
|
|
|
|
|
4,586 |
|
Gain (loss) on disposal of discontinued operations,
net of income taxes |
|
|
36 |
|
|
|
(57 |
) |
|
|
(322 |
) |
|
|
(73 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
|
2,845 |
|
|
|
5,058 |
|
|
|
(28,314 |
) |
|
|
24,501 |
|
Less: Net income attributable to noncontrolling interests |
|
|
728 |
|
|
|
448 |
|
|
|
1,712 |
|
|
|
1,386 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to Ferro Corporation |
|
|
2,117 |
|
|
|
4,610 |
|
|
|
(30,026 |
) |
|
|
23,115 |
|
Dividends on preferred stock |
|
|
(168 |
) |
|
|
(225 |
) |
|
|
(538 |
) |
|
|
(675 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to Ferro Corporation
common shareholders |
|
$ |
1,949 |
|
|
$ |
4,385 |
|
|
$ |
(30,564 |
) |
|
$ |
22,440 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts attributable to Ferro Corporation: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations, net of tax |
|
$ |
2,081 |
|
|
$ |
3,408 |
|
|
$ |
(29,704 |
) |
|
$ |
18,602 |
|
Income (loss) from discontinued operations, net of tax |
|
|
36 |
|
|
|
1,202 |
|
|
|
(322 |
) |
|
|
4,513 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
2,117 |
|
|
$ |
4,610 |
|
|
$ |
(30,026 |
) |
|
$ |
23,115 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Per common share data |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted earnings (loss) attributable to
Ferro Corporation common shareholders: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
From continuing operations |
|
$ |
0.04 |
|
|
$ |
0.07 |
|
|
$ |
(0.68 |
) |
|
$ |
0.41 |
|
From discontinued operations |
|
|
0.00 |
|
|
|
0.03 |
|
|
|
(0.01 |
) |
|
|
0.10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
0.04 |
|
|
$ |
0.10 |
|
|
$ |
(0.69 |
) |
|
$ |
0.51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends declared |
|
$ |
0.00 |
|
|
$ |
0.145 |
|
|
$ |
0.01 |
|
|
$ |
0.435 |
|
See accompanying notes to condensed consolidated financial statements.
3
Ferro Corporation and Consolidated Subsidiaries
Condensed Consolidated Balance Sheets
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
|
December 31, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
ASSETS
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
14,271 |
|
|
$ |
10,191 |
|
Accounts and trade notes receivable, net |
|
|
309,100 |
|
|
|
296,423 |
|
Inventories |
|
|
181,249 |
|
|
|
256,411 |
|
Deposits for precious metals |
|
|
92,330 |
|
|
|
|
|
Deferred income taxes |
|
|
27,264 |
|
|
|
19,167 |
|
Other receivables |
|
|
27,509 |
|
|
|
58,391 |
|
Other current assets |
|
|
10,486 |
|
|
|
8,306 |
|
|
|
|
|
|
|
|
Total current assets |
|
|
662,209 |
|
|
|
648,889 |
|
Other assets |
|
|
|
|
|
|
|
|
Property, plant and equipment, net |
|
|
443,160 |
|
|
|
456,549 |
|
Goodwill |
|
|
222,403 |
|
|
|
229,665 |
|
Amortizable intangible assets, net |
|
|
11,042 |
|
|
|
11,753 |
|
Deferred income taxes |
|
|
150,985 |
|
|
|
134,361 |
|
Other non-current assets |
|
|
68,504 |
|
|
|
62,900 |
|
|
|
|
|
|
|
|
Total assets |
|
$ |
1,558,303 |
|
|
$ |
1,544,117 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS EQUITY
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
Loans payable and current portion of long-term debt |
|
$ |
38,491 |
|
|
$ |
8,883 |
|
Accounts payable |
|
|
219,273 |
|
|
|
232,113 |
|
Income taxes |
|
|
3,407 |
|
|
|
14,361 |
|
Accrued payrolls |
|
|
19,979 |
|
|
|
18,695 |
|
Accrued expenses and other current liabilities |
|
|
70,092 |
|
|
|
83,012 |
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
351,242 |
|
|
|
357,064 |
|
Other liabilities |
|
|
|
|
|
|
|
|
Long-term debt, less current portion |
|
|
582,536 |
|
|
|
561,613 |
|
Postretirement and pension liabilities |
|
|
232,166 |
|
|
|
221,110 |
|
Deferred income taxes |
|
|
11,778 |
|
|
|
13,011 |
|
Other non-current liabilities |
|
|
32,797 |
|
|
|
34,047 |
|
|
|
|
|
|
|
|
Total liabilities |
|
|
1,210,519 |
|
|
|
1,186,845 |
|
Series A convertible preferred stock (approximates redemption value) |
|
|
9,544 |
|
|
|
11,548 |
|
Shareholders equity |
|
|
|
|
|
|
|
|
Ferro Corporation shareholders equity: |
|
|
|
|
|
|
|
|
Common stock |
|
|
52,323 |
|
|
|
52,323 |
|
Paid-in capital |
|
|
156,505 |
|
|
|
178,420 |
|
Retained earnings |
|
|
370,524 |
|
|
|
401,186 |
|
Accumulated other comprehensive loss |
|
|
(78,628 |
) |
|
|
(98,436 |
) |
Common shares in treasury, at cost |
|
|
(171,914 |
) |
|
|
(197,524 |
) |
|
|
|
|
|
|
|
Total Ferro Corporation shareholders equity |
|
|
328,810 |
|
|
|
335,969 |
|
Noncontrolling interests |
|
|
9,430 |
|
|
|
9,755 |
|
|
|
|
|
|
|
|
Total equity |
|
|
338,240 |
|
|
|
345,724 |
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity |
|
$ |
1,558,303 |
|
|
$ |
1,544,117 |
|
|
|
|
|
|
|
|
See accompanying notes to condensed consolidated financial statements.
4
Ferro Corporation and Consolidated Subsidiaries
Condensed Consolidated Statements of Shareholders Equity and Comprehensive Income (Loss)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ferro Corporation Shareholders |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other |
|
|
|
|
|
|
|
|
|
Common Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive |
|
|
Non- |
|
|
|
|
|
|
in Treasury |
|
|
Common |
|
|
Paid-in |
|
|
Retained |
|
|
Income |
|
|
controlling |
|
|
Total |
|
|
|
Shares |
|
|
Amount |
|
|
Stock |
|
|
Capital |
|
|
Earnings |
|
|
(Loss) |
|
|
Interests |
|
|
Equity |
|
|
|
(In thousands) |
|
Balances at December 31, 2007 |
|
|
8,753 |
|
|
$ |
(202,855 |
) |
|
$ |
52,323 |
|
|
$ |
166,391 |
|
|
$ |
468,190 |
|
|
$ |
(7,765 |
) |
|
$ |
9,896 |
|
|
$ |
486,180 |
|
Net income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23,115 |
|
|
|
|
|
|
|
1,386 |
|
|
|
24,501 |
|
Other comprehensive income (loss),
net of tax: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation
adjustment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(15,014 |
) |
|
|
290 |
|
|
|
(14,724 |
) |
Postretirement benefit
liability adjustments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,676 |
|
|
|
|
|
|
|
2,676 |
|
Raw material commodity swap
adjustments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
454 |
|
|
|
|
|
|
|
454 |
|
Interest rate swap adjustments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
456 |
|
|
|
|
|
|
|
456 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,363 |
|
Cash dividends: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(18,883 |
) |
|
|
|
|
|
|
|
|
|
|
(18,883 |
) |
Preferred |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(675 |
) |
|
|
|
|
|
|
|
|
|
|
(675 |
) |
Income tax expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32 |
|
Stock-based compensation
transactions |
|
|
(173 |
) |
|
|
2,606 |
|
|
|
|
|
|
|
682 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,288 |
|
Issuance of Convertible Notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,406 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12,406 |
|
Distributions to noncontrolling interests |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1,254 |
) |
|
|
(1,254 |
) |
Adjustment to initially apply FAS No. 158
as of January 1, 2008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(505 |
) |
|
|
366 |
|
|
|
|
|
|
|
(139 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at September 30, 2008 |
|
|
8,580 |
|
|
$ |
(200,249 |
) |
|
$ |
52,323 |
|
|
$ |
179,511 |
|
|
$ |
471,242 |
|
|
$ |
(18,827 |
) |
|
$ |
10,318 |
|
|
$ |
494,318 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at December 31, 2008 |
|
|
8,432 |
|
|
$ |
(197,524 |
) |
|
$ |
52,323 |
|
|
$ |
178,420 |
|
|
$ |
401,186 |
|
|
$ |
(98,436 |
) |
|
$ |
9,755 |
|
|
$ |
345,724 |
|
Net (loss) income |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(30,026 |
) |
|
|
|
|
|
|
1,712 |
|
|
|
(28,314 |
) |
Other comprehensive income (loss),
net of tax: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation
adjustment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17,541 |
|
|
|
(1 |
) |
|
|
17,540 |
|
Postretirement benefit
liability adjustments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
163 |
|
|
|
|
|
|
|
163 |
|
Raw material commodity swap
adjustments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
577 |
|
|
|
|
|
|
|
577 |
|
Interest rate swap adjustments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,527 |
|
|
|
|
|
|
|
1,527 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(8,507 |
) |
Cash dividends: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(437 |
) |
|
|
|
|
|
|
|
|
|
|
(437 |
) |
Preferred |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(199 |
) |
|
|
|
|
|
|
|
|
|
|
(199 |
) |
Income tax expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
Stock-based compensation
transactions |
|
|
(1,038 |
) |
|
|
25,610 |
|
|
|
|
|
|
|
(21,916 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,694 |
|
Distributions to noncontrolling interests |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(2,036 |
) |
|
|
(2,036 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balances at September 30, 2009 |
|
|
7,394 |
|
|
$ |
(171,914 |
) |
|
$ |
52,323 |
|
|
$ |
156,505 |
|
|
$ |
370,524 |
|
|
$ |
(78,628 |
) |
|
$ |
9,430 |
|
|
$ |
338,240 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See accompanying notes to condensed consolidated financial statements.
5
Ferro Corporation and Consolidated Subsidiaries
Condensed Consolidated Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
Nine months ended |
|
|
|
September 30, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Cash flows from operating activities |
|
|
|
|
|
|
|
|
Net (loss) income |
|
$ |
(28,314 |
) |
|
$ |
24,501 |
|
Depreciation and amortization |
|
|
63,501 |
|
|
|
55,596 |
|
Precious metals deposits |
|
|
(92,330 |
) |
|
|
|
|
Accounts and trade notes receivable |
|
|
(5,531 |
) |
|
|
(13,270 |
) |
Inventories |
|
|
77,477 |
|
|
|
(45,980 |
) |
Accounts payable |
|
|
(10,758 |
) |
|
|
(2,781 |
) |
Other changes in current assets and liabilities, net |
|
|
8,774 |
|
|
|
(3,147 |
) |
Other adjustments, net |
|
|
(18,263 |
) |
|
|
(15,249 |
) |
|
|
|
|
|
|
|
Net cash used for continuing operations |
|
|
(5,444 |
) |
|
|
(330 |
) |
Net cash (used for) provided by discontinued operations |
|
|
(325 |
) |
|
|
2,168 |
|
|
|
|
|
|
|
|
Net cash (used for) provided by operating activities |
|
|
(5,769 |
) |
|
|
1,838 |
|
Cash flows from investing activities |
|
|
|
|
|
|
|
|
Capital expenditures for property, plant and equipment of continuing operations |
|
|
(30,704 |
) |
|
|
(49,695 |
) |
Capital expenditures for property, plant and equipment of discontinued
operations |
|
|
|
|
|
|
(2,110 |
) |
Expenditures for other assets |
|
|
|
|
|
|
(3,400 |
) |
Proceeds from sale of assets and businesses |
|
|
104 |
|
|
|
586 |
|
Dividends received from affiliates |
|
|
169 |
|
|
|
336 |
|
|
|
|
|
|
|
|
Net cash used for investing activities |
|
|
(30,431 |
) |
|
|
(54,283 |
) |
Cash flows from financing activities |
|
|
|
|
|
|
|
|
Net borrowings under short-term facilities |
|
|
29,128 |
|
|
|
2,102 |
|
Proceeds from convertible notes |
|
|
|
|
|
|
172,500 |
|
Proceeds from revolving credit facility |
|
|
561,624 |
|
|
|
756,440 |
|
Entinguishment of 9 1/8% notes |
|
|
|
|
|
|
(205,269 |
) |
Principal payments on revolving credit facility |
|
|
(542,027 |
) |
|
|
(638,227 |
) |
Principal payments on term loan facility |
|
|
(2,287 |
) |
|
|
(8,689 |
) |
Debt issue costs |
|
|
(9,367 |
) |
|
|
(5,462 |
) |
Cash dividends paid |
|
|
(636 |
) |
|
|
(19,558 |
) |
Other financing activities |
|
|
748 |
|
|
|
1,522 |
|
|
|
|
|
|
|
|
Net cash provided by financing activities |
|
|
37,183 |
|
|
|
55,359 |
|
Effect of exchange rate changes on cash and cash equivalents |
|
|
3,097 |
|
|
|
(415 |
) |
|
|
|
|
|
|
|
Increase in cash and cash equivalents |
|
|
4,080 |
|
|
|
2,499 |
|
Cash and cash equivalents at beginning of period |
|
|
10,191 |
|
|
|
12,025 |
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period |
|
$ |
14,271 |
|
|
$ |
14,524 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash paid during the period for: |
|
|
|
|
|
|
|
|
Interest |
|
$ |
37,985 |
|
|
$ |
46,247 |
|
Income taxes |
|
$ |
8,221 |
|
|
$ |
8,379 |
|
See accompanying notes to condensed consolidated financial statements.
6
Ferro Corporation and Consolidated Subsidiaries
Notes to Condensed Consolidated Financial Statements
1. Basis of Presentation
Ferro Corporation (Ferro, we, us or the Company) prepared these unaudited condensed
consolidated financial statements of Ferro Corporation and its consolidated subsidiaries in
accordance with accounting principles generally accepted in the United States of America
(U.S. GAAP) for interim financial information and with the instructions to Form 10-Q and Article
10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes
required by U.S. GAAP for complete financial statements and, therefore, should be read in
conjunction with the consolidated financial statements and related notes included in our Annual
Report on Form 10-K for the year ended December 31, 2008. The preparation of financial statements
in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the timing
and amount of assets, liabilities, equity, revenues and expenses reported and disclosed. Actual
amounts could differ from our estimates, resulting in changes in revenues or costs that could have
a material impact on the Companys results of operations, financial position, or cash flows. In
our opinion, we made all adjustments that are necessary for a fair presentation, and those
adjustments are of a normal recurring nature unless otherwise noted. Due to differing business
conditions, our various initiatives, and some seasonality, the results for the three and nine
months ended September 30, 2009, are not necessarily indicative of the results expected in
subsequent quarters or for the full year. We evaluated subsequent events through October 26, 2009,
when the financial statements were issued.
2. Accounting Standards Adopted in the Nine Months Ended September 30, 2009
On January 1, 2009, we adopted Financial Accounting Standards Board (FASB) Statement
No. 141(R), Business Combinations, (FAS No. 141(R)) and FASB Staff Position (FSP)
No. FAS 141(R)-1, Accounting for Assets Acquired and Liabilities Assumed in a Business Combination
That Arise From Contingencies, which are codified in FASB Accounting Standards
CodificationTM (ASC) Topic 805, Business Combinations. These statements require more
acquired assets and assumed liabilities to be measured at fair value as of the acquisition date,
liabilities related to contingent consideration to be remeasured at fair value in each subsequent
reporting period, and all acquisition-related costs in preacquisition periods to be expensed. We
will apply these standards to any business combination beginning in 2009 and therefore, adoption of
these standards did not have an effect on our consolidated financial statements.
On January 1, 2009, we adopted Emerging Issues Task Force (EITF) Issue No. 08-7, Accounting
for Defensive Intangible Assets, (EITF No. 08-7), which is codified in ASC Subtopic 350-30,
General Intangibles Other than Goodwill. This pronouncement requires us to prospectively account
for an acquired defensive asset as a separate unit of accounting and assign it a useful life based
on the period during which the asset would diminish in value. With our adoption of FAS No. 141(R)
also on January 1, 2009, we will assign an acquired defensive asset a fair value based on what a
willing market participant would pay for such an asset and amortize it over the time period that a
market participant would derive cash flows from the asset. Impairment testing will be performed on
defensive assets with finite lives under ASC Topic 360, Property, Plant, and Equipment, and those
with infinite lives under ASC Topic 350, Intangibles Goodwill and Other. We will apply this
standard to any business combination or any acquisition of a defensive asset beginning in 2009 and
therefore, the adoption of EITF No. 08-7 did not have an effect on our consolidated financial
statements.
On January 1, 2009, we adopted FSP No. FAS 142-3, Determination of the Useful Life of
Intangible Assets, (FSP No. FAS 142-3), which is codified primarily in ASC Subtopic 350-30,
General Intangibles Other than Goodwill. This pronouncement prospectively amends the factors that
should be considered in developing renewal or extension assumptions used to determine the useful
life of a recognized intangible asset under ASC Topic 350, Intangibles Goodwill and Other. We
amended our policies to establish the useful life of intangible assets considering the period of
expected cash flows to be received from the intangible asset based on the expected use of the asset
and our historical experience in renewing or extending similar arrangements. In the absence of
that experience, we consider the assumptions that market participants would use about renewal or
extension consistent with the highest and best use of the asset by market participants. Annually,
we will disclose our accounting policy for costs incurred to extend or renew recognized intangible
assets and the weighted-average period prior to the next renewal or extension by major intangible
class. Adoption of FSP No. FAS 142-3 did not have a material effect on our consolidated financial
statements.
7
On January 1, 2009, we adopted FASB Statement No. 160, Noncontrolling Interests in
Consolidated Financial Statements an amendment of ARB No. 51, (FAS No. 160), which is codified
in ASC Topic 810, Consolidation. Under this statement, noncontrolling interests (e.g., minority
interests) in subsidiaries are measured initially at fair value and classified as a separate
component of equity and the amount of net income attributable to noncontrolling interests is
included in consolidated net income. FAS No. 160 requires entities to apply the measurement
requirements prospectively and to apply the presentation and disclosure requirements
retrospectively to comparative financial statements. As a result, we classified minority interests
in consolidated subsidiaries of $9.4 million at September 30, 2009, and $9.8 million at
December 31, 2008, in equity, and included net income attributable to minority interests of
$0.7 million and $0.5 million for the three months ended September 30, 2009 and 2008, respectively,
and $1.7 million and $1.4 million for the nine months ended September 30, 2009 and 2008,
respectively, in consolidated net income.
On January 1, 2009, we adopted FASB Statement No. 161, Disclosures about Derivative
Instruments and Hedging Activities an amendment of FASB Statement No. 133, which is codified in
ASC Topic 815, Derivatives and Hedging. This Statement requires enhanced disclosures about an
entitys derivative and hedging activities and encourages, but does not require, comparative
disclosures for earlier periods at initial adoption. The additional disclosures about our
derivative and hedging activities did not have a material impact on our consolidated financial
statements.
On January 1, 2009, we adopted FSP No. APB 14-1, Accounting for Convertible Debt Instruments
That May Be Settled in Cash upon Conversion (Including Partial Cash Settlement), (FSP
No. APB 14-1), which is codified primarily in ASC Subtopic 470-20, Debt with Conversion and Other
Options. This pronouncement specifies that issuers of such instruments should separately account
for the liability and equity components in a manner that will reflect the entitys nonconvertible
debt borrowing rate when interest cost is recognized in subsequent periods. FSP No. APB 14-1 is to
be applied retrospectively. As a result, the carrying value of the liability component of the
6.50% Convertible Senior Notes was reduced by $16.5 million and $19.0 million at September 30,
2009, and December 31, 2008, respectively. Related deferred tax liabilities were increased by
$7.0 million and $7.0 million, paid-in capital was increased by $12.4 million and $12.4 million,
and retained earnings was decreased by $2.3 million and $0.7 million at September 30, 2009, and
December 31, 2008, respectively. Loss from continuing operations was increased by $0.6 million and
$0.2 million, net loss was increased by $0.6 million and $0.2 million, and basic and diluted loss
per share was increased by $0.01 and $0.01 for the three months ended September 30, 2009 and 2008,
respectively. Loss from continuing operations was increased by $1.6 million and $0.2 million, net
loss was increased by $1.6 million and $0.2 million, and basic and diluted loss per share was
increased by $0.03 and $0.01 for the nine months ended September 30, 2009 and 2008, respectively.
On January 1, 2009, we adopted EITF Issue No. 07-5, Determining Whether an Instrument (or an
Embedded Feature) Is Indexed to an Entitys Own Stock, (EITF No. 07-5), which is codified
primarily in ASC Subtopic 815-40, Contracts in Entitys Own Equity. ASC Topic 815, Derivatives and
Hedging, specifies that a contract issued or held by a company that is both indexed to its own
stock and classified in stockholders equity is not considered a derivative instrument for purposes
of applying this topic. EITF No. 07-5 provides further guidance in requiring that both an
instruments contingency exercise provisions and its settlement provisions be evaluated for
determining whether the instrument (or embedded feature) is indexed solely to an entitys own
stock. Adoption of EITF No. 07-5 did not change the conclusions we reached in the adoption of FSP
No. APB 14-1 and, therefore, did not have an effect on our consolidated financial statements.
On January 1, 2009, we adopted EITF Issue No. 08-6, Equity Method Investment Accounting
Considerations, (EITF No. 08-6), which is codified in ASC Topic 323, Investments Equity Method
and Joint Ventures. This pronouncement changes the way we account for equity method investments.
Among other things, it requires us to determine the initial carrying value of an equity method
investment by applying the cost accumulation model and to account for share issuances by the
investee as a proportionate sale of its investment. EITF No. 08-6 is to be applied prospectively,
and its adoption did not have an effect on our consolidated financial statements.
On January 1, 2009, we adopted FSP No. FAS 132(R)-1, Employers Disclosures About
Postretirement Benefit Plan Assets, which is codified in ASC Subtopic 715-20, Defined Benefit Plans
- General. This pronouncement requires for annual periods more detailed disclosures about
employers plan assets, including employers investment strategies, major categories of plan
assets, concentrations of risk within plan assets, and valuation techniques used to measure the
fair value of plan assets. Other than for some additional disclosures in our Annual Report on
Form 10-K, adoption of this FASB Staff Position will not have an effect on our consolidated
financial statements.
8
On January 1, 2009, we adopted the provisions of FASB Statement No. 157, Fair Value
Measurements, for all nonrecurring fair value measurements of nonfinancial assets and nonfinancial
liabilities, which had been delayed by FSP No. FAS 157-2, Effective Date of FASB Statement No. 157.
Both pronouncements are codified in ASC Topic 820, Fair Value Measurements and Disclosures.
Adoption of these provisions had no effect on our consolidated financial statements.
On January 1, 2009, we adopted FSP No. EITF 03-6-1, Determining Whether Instruments Granted in
Share-Based Payment Transactions Are Participating Securities, which is codified in ASC Topic 260,
Earnings Per Share. This pronouncement establishes that unvested share-based payment awards that
contain nonforfeitable rights to dividends are participating securities and shall be included in
the computation of earnings per share under the two-class method. Adoption of this FASB Staff
Position did not have a material effect on our consolidated financial statements.
On January 1, 2009, we early adopted FSP No. FAS 157-4, Determining Fair Value When the Volume
and Level of Activity for the Asset or Liability Have Significantly Decreased and Identifying
Transactions That Are Not Orderly, (FSP No. FAS 157-4), which is codified in ASC Topic 820, Fair
Value Measurements and Disclosures. This pronouncement provides guidance on (1) estimating the
fair value of an asset or liability when the volume and level of activity for the asset or
liability have significantly decreased and (2) identifying transactions that are not orderly. FSP
No. FAS 157-4 requires entities to disclose in interim and annual periods the inputs and valuation
techniques used to measure fair value. Adoption of this FASB Staff Position did not have a
material effect on our consolidated financial statements.
On January 1, 2009, we early adopted FSP No. FAS 107-1 and APB 28-1, Interim Disclosures about
Fair Value of Financial Instruments, which is codified in ASC Topic 825, Financial Instruments.
This pronouncement expands the fair value disclosures for financial instruments to interim periods
for publicly traded entities. It also requires disclosure of the methods and significant
assumptions used to estimate the fair value of financial instruments and any changes of the methods
and significant assumptions from prior periods. Adoption of this FASB Staff Position did not have
a material effect on our consolidated financial statements.
On January 1, 2009, we early adopted FSP No. FAS 115-2 and FAS 124-2, Recognition and
Presentation of Other-Than-Temporary Impairments, which is codified in ASC Topic 320, Investments
Debt and Equity Securities. This pronouncement modifies the existing other-than-temporary
impairment model for investments in debt securities and amends disclosure provisions for
investments in debt and equity securities. Adoption of this FASB Staff Position did not have an
effect on our consolidated financial statements.
On April 1, 2009, we adopted FASB Statement No. 165, Subsequent Events, (FAS No. 165), which
is codified in ASC Topic 855, Subsequent Events. This statement establishes principles and
requirements for managements evaluation of events or transactions occurring after the balance
sheet date for potential recognition or disclosure, the circumstances under which those events or
transactions are recognized, and the related disclosures. Adoption of FAS No. 165 did not have a
material effect on our consolidated financial statements.
On September 30, 2009, we adopted FASB Accounting Standards Update (ASU) 2009-01, Topic 105
Generally Accepted Accounting Principles, (ASU 2009-01). This pronouncement establishes the
ASC as the source of authoritative accounting principles recognized by the FASB to be used by
nongovernmental entities in the preparation of financial statements that are presented in
conformity with generally accepted accounting principles in the United States. Adoption of
ASU 2009-01 did not have a material effect on our consolidated financial statements.
On September 30, 2009, we early adopted ASU 2009-05, Fair Value Measurements and Disclosures
Measuring Liabilities at Fair Value, (ASU 2009-05), which is codified in ASC Topic 820, Fair
Value Measurements and Disclosures. ASU 2009-05 requires that when a quoted price in an active
market for the identical liability is not available, the liabilitys fair value is measured with a
valuation technique that uses the quoted price for the identical liability when traded as an asset
or quoted prices for similar liabilities or similar liabilities when traded as assets or with
another valuation technique consistent with the principles of ASC Topic 820. Adoption of ASU
2009-05 did not have an effect on our financial statements.
9
3. Newly Issued Accounting Pronouncements
In June 2009, the FASB issued Statement No. 166, Accounting for Transfers of Financial Assets
an amendment of FASB Statement No. 140, (FAS No. 166), which is not yet codified. This
pronouncement amends guidance in ASC Topic 860, Transfers and Servicing, for derecognition of
transferred financial assets. FAS No. 166 is effective for financial asset transfers occurring
after the beginning of our fiscal year that begins January 1, 2010. Early adoption of FAS No. 166
is prohibited. We are evaluating the impact that the adoption of FAS No. 166 may have on our
consolidated financial statements.
In June 2009, the FASB issued Statement No. 167, Amendments to FASB Interpretation No. 46(R),
(FAS No. 167), which is not yet codified. This pronouncement amends the consolidation guidance
that applies to variable interest entities (VIEs). FAS No. 167 is effective for our fiscal year
that begins January 1, 2010, and early adoption is prohibited. We are evaluating the impact that
the adoption of FAS No. 167 may have on our consolidated financial statements.
4. Inventories
Inventories consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
|
December 31, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Raw materials |
|
$ |
52,245 |
|
|
$ |
82,837 |
|
Work in process |
|
|
38,578 |
|
|
|
43,224 |
|
Finished goods |
|
|
90,426 |
|
|
|
130,350 |
|
|
|
|
|
|
|
|
Total |
|
$ |
181,249 |
|
|
$ |
256,411 |
|
|
|
|
|
|
|
|
In the production of some of our products, we use precious metals, some of which we obtain
from financial institutions under consignment agreements with terms of one year or less. The
financial institutions retain ownership of the precious metals and charge us fees based on the
amounts we consign. These fees were $0.9 million and $1.1 million for the three months ended
September 30, 2009 and 2008, respectively, and $3.4 million and $3.4 million for the nine months
ended September 30, 2009 and 2008, respectively, and were charged to cost of sales. We had on hand
precious metals owned by participants in our precious metals program of $82.0 million at
September 30, 2009, and $104.2 million at December 31, 2008, measured at fair value based on market
prices for identical assets.
5. Property, Plant and Equipment
Property, plant and equipment is reported net of accumulated depreciation of $643.8 million at
September 30, 2009, and $579.8 million at December 31, 2008. Unpaid capital expenditure
liabilities, representing noncash investing activities, were $8.8 million at September 30, 2009,
and $11.7 million at September 30, 2008.
6. Goodwill and Other Intangible Assets
A summary of goodwill activity follows:
|
|
|
|
|
|
|
(Dollars in |
|
|
|
thousands) |
|
Balance at December 31, 2008 |
|
$ |
229,665 |
|
Impairment |
|
|
(8,225 |
) |
Currency translation adjustments |
|
|
963 |
|
|
|
|
|
Balance at September 30, 2009 |
|
$ |
222,403 |
|
|
|
|
|
10
Details of amortizable intangible assets follow:
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
|
December 31, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Patents |
|
$ |
5,851 |
|
|
$ |
5,775 |
|
Other |
|
|
14,492 |
|
|
|
14,451 |
|
|
|
|
|
|
|
|
Total gross amortizable intangible assets |
|
|
20,343 |
|
|
|
20,226 |
|
Accumulated amortization |
|
|
(9,301 |
) |
|
|
(8,473 |
) |
|
|
|
|
|
|
|
Amortizable intangible assets, net |
|
$ |
11,042 |
|
|
$ |
11,753 |
|
|
|
|
|
|
|
|
Amortization expense for amortizable intangible assets was $0.3 million and $0.2 million for
the three months ended September 30, 2009 and 2008, respectively, and $0.8 million and $0.7 million
for the nine months ended September 30, 2009 and 2008, respectively. Aggregate amortization
expense for intangible assets is expected to be $0.9 million annually in the years 2009 through
2013.
We test goodwill for impairment annually using October 31st as our annual assessment date,
primarily due to the timing of our annual budgeting process, or more frequently if we believe
indicators of impairment exist. ASC Subtopic 350-20, Goodwill, requires an assessment consisting
of two steps. In the first step, we test goodwill for impairment by comparing the fair value of
each reporting unit that has goodwill against its carrying value, including the allocation of
certain corporate assets and liabilities. If the carrying value of the reporting unit exceeds its
fair value, we perform a second step to measure impairment.
We estimate the fair values of all reporting units using the weighted average of both the
income approach and the market approach, which we believe provides a reasonable estimate of a
reporting units fair value. The income approach uses projected cash flows attributable to the
reporting unit over the useful life and discounted to its present value. The market approach
estimates a price reasonably expected to be realized from the sale of similar businesses. Factors
considered in both of these approaches included projections of our future operating results,
anticipated future cash flows, comparable marketplace data adjusted for our industry grouping, and
the cost of capital. These factors contain significant unobservable inputs (Level 3), primarily
internally developed cash flow projections.
In 2008, our Tile Coating Systems and Specialty Plastics businesses had indicators of
impairment but the step two analyses required to complete the measurement of the amount of goodwill
impairment was not completed prior to the issuance of our December 31, 2008 financial statements.
As a result, at December 31, 2008, we recorded estimated goodwill impairments of $41.4 million for
the Tile Coating Systems business and $17.0 million related to the Specialty Plastics business.
These impairments fully impaired the goodwill for each of these reporting units, based upon the
available evidence and analysis performed to date and the amounts were included in impairment
charges in the consolidated statements of operations for the year ended December 31, 2008. Upon
completion of the step two analyses in 2009, there were no adjustments necessary.
The significant decrease in the market price of the Companys common stock at the end of
February 2009 was an indicator of potential goodwill impairment. At that time we compared the
carrying value of all reporting units that had goodwill against their fair values and determined
that all fair values exceeded the respective carrying values. We believe that the factors leading
to the overall decline in market capitalization were primarily attributable to Ferro Corporation
and unrelated to our reporting units.
In the third quarter of 2009, an indicator of potential goodwill impairment for our
Pharmaceuticals business was triggered by changes made to the assumptions used to determine
valuation under the market approach. We compared the carrying value of this reporting unit against
its fair value, and determined that the carrying value exceeded the fair value. The step two
analyses required to complete the measurement of the amount of goodwill impairment are not
complete. As a result, at September 30, 2009, we recorded an estimated goodwill impairment charge
of $8.2 million for the Pharmaceuticals business. We believe that this impairment charge, which
fully impairs the goodwill for this business, is our best estimate based upon the available
evidence and the analysis performed to date. The amount is included in impairment charges in the
Condensed Consolidated Statements of Operations and may be adjusted upon the completion of the step
two analyses in the fourth quarter of 2009.
11
7. Financing and Long-term Debt
Loans payable and current portion of long-term debt consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
|
December 31, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Loans payable to banks |
|
$ |
5,445 |
|
|
$ |
4,754 |
|
Accounts receivable asset securitization
program |
|
|
28,557 |
|
|
|
|
|
Current portion of long-term debt |
|
|
4,489 |
|
|
|
4,129 |
|
|
|
|
|
|
|
|
Total |
|
$ |
38,491 |
|
|
$ |
8,883 |
|
|
|
|
|
|
|
|
Long-term debt consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
|
December 31, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
$172.5 million 6.50% Convertible Senior
Notes, net of unamortized discounts |
|
$ |
156,004 |
|
|
$ |
153,451 |
|
Revolving credit facility |
|
|
131,400 |
|
|
|
111,803 |
|
Term loan facility |
|
|
290,211 |
|
|
|
292,498 |
|
Capitalized lease obligations |
|
|
6,637 |
|
|
|
6,447 |
|
Other notes |
|
|
2,773 |
|
|
|
1,543 |
|
|
|
|
|
|
|
|
|
|
|
587,025 |
|
|
|
565,742 |
|
Less current portion |
|
|
(4,489 |
) |
|
|
(4,129 |
) |
|
|
|
|
|
|
|
Total |
|
$ |
582,536 |
|
|
$ |
561,613 |
|
|
|
|
|
|
|
|
6.50% Convertible Senior Notes
In 2008, Ferro issued $172.5 million of 6.50% Convertible Senior Notes due 2013 (the
Convertible Notes). The proceeds from the offering, along with available cash, including
borrowings under Ferros revolving credit facility, were used to purchase all of Ferros
outstanding 9 1/8% Senior Notes due 2009. The Convertible Notes bear interest at a rate of 6.5%
per year, payable semi-annually in arrears on February 15th and August 15th of each year, beginning
on February 15, 2009. The Convertible Notes mature on August 15, 2013. Under certain
circumstances, holders of the Convertible Notes may convert their notes prior to maturity.
The initial base conversion rate is 30.9253, equivalent to an initial base conversion price of
$32.34 per share of our common stock. If the price of our common stock at conversion exceeds the
base conversion price, the base conversion rate is increased by an additional number of shares.
The base conversion rate and the additional number of shares are adjusted in certain events. Upon
conversion of Convertible Notes, we will pay the conversion value in cash up to the aggregate
principal amount of the Convertible Notes being converted and in shares of our common stock, for
the remainder, if any. Upon a fundamental change, holders may require us to repurchase Convertible
Notes for cash equal to the principal amount plus accrued and unpaid interest. The Convertible
Notes are unsecured obligations and rank equally in right of payment with any other unsecured,
unsubordinated obligations.
We separately account for the liability and equity components of the Convertible Notes in a
manner that will reflect our nonconvertible debt borrowing rate when interest cost is recognized in
subsequent periods. The effective interest rate on the liability component is 9.5%. Contractual
interest was $2.8 million and $1.3 million and amortization of the liability discount was
$0.9 million and $0.4 million for the three months ended September 30, 2009 and 2008, respectively.
Contractual interest was $8.4 million and $1.3 million and amortization of the liability discount
was $2.6 million and $0.4 million for the nine months ended September 30, 2009 and 2008,
respectively. At September 30, 2009, the remaining period over which the liability discount will
be amortized was 3.9 years. The unamortized liability discount was $16.5 million at September 30,
2009, and $19.0 million at December 31, 2008. The carrying amount of the equity component was
$12.4 million at September 30, 2009, and $12.4 million at December 31, 2008.
12
Revolving Credit and Term Loan Facilities
In 2006, we entered into an agreement with a group of lenders for a $700 million credit
facility, consisting of a multi-currency senior revolving credit facility and a senior term loan
facility, which replaced a former revolving credit facility that would have expired later that
year. In 2007, we cancelled the unused portion of the term loan facility and amended the credit
facility (the 2007 Amended Credit Facility) primarily to increase the size of the revolving
credit facility, reduce interest rates, and increase operating flexibility. On March 11, 2009, we
amended the 2007 Amended Credit Facility (the 2009 Amended Credit Facility) primarily to provide
additional operating flexibility and to change pricing to more accurately reflect current market
interest rates. The amendment was filed as Exhibit 10.1 to our Annual Report on Form 10-K for the
year ended December 31, 2008. The primary effects of the 2009 Amended Credit Facility were to:
|
|
|
Increase the interest rates and commitment fees payable thereunder pursuant to a grid
structure based on our leverage ratio, |
|
|
|
Increase the maximum permitted quarterly leverage ratio and decrease the minimum
permitted quarterly fixed charge coverage ratio, |
|
|
|
Add a minimum cumulative EBITDA requirement for each quarter in 2009, |
|
|
|
Restrict the Companys ability to engage in acquisitions and make investments, |
|
|
|
Limit the amount of cash and cash equivalent collateral the Company is permitted to
deliver to participants in our precious metals program to secure our obligations arising
under the precious metals consignment agreements, |
|
|
|
Require additional financial reporting by the Company to the lenders, |
|
|
|
Increase the amount of the annual excess cash flow required to be used to repay term
loans, |
|
|
|
Require application of the net proceeds of certain dispositions, but excluding the first
$20 million of such net proceeds, to be applied to repay debt outstanding under the
revolving credit facility and term loans and to permanently reduce availability under the
revolving loan facility on a dollar for dollar basis, provided that we are not required to
reduce the commitments under the revolving credit facility to below $150 million, |
|
|
|
Eliminate our ability to request an increase of $50 million in the revolving credit
facility, |
|
|
|
Add provisions governing the obligations of the Company and the lenders if one or more
lenders under the revolving credit facility fails to satisfy its funding obligations or
otherwise becomes a defaulting lender, and |
|
|
|
Restrict our ability to make payments with respect to our capital securities. The 2009
Amended Credit Facility effectively prohibits us from paying dividends on our preferred and
common stock beginning in the second quarter of 2009. |
The 2009 Amended Credit Facility currently includes a $300.0 million revolving credit
facility, which matures in 2011. We had $161.7 million at September 30, 2009, and $180.0 million
at December 31, 2008, available under the revolving credit facility, after reductions for standby
letters of credit secured by this facility. At September 30, 2009, the 2009 Amended Credit
Facility also included a term loan facility with an outstanding principal balance of
$290.2 million, which matures in 2012. We make periodic principal payments on the term loans. We
are required to make minimum quarterly principal payments of $0.8 million from October 2009 to July
2011. During the last year of the loans life, we are required to repay the remaining balance of
the term loans in four quarterly installments. Currently, those last four payments will be
$71.0 million each. In addition to the minimum quarterly payments, each April we may be required
to make an additional principal payment. The amount of this additional payment is dependent on the
Companys leverage and certain cash flow metrics. Any additional payment that is required reduces,
on a dollar-for-dollar basis, the amount due in the last four quarterly payments. We were not
required to make an additional principal payment in April 2009.
13
The interest rates under the 2009 Amended Credit Facility are the sum of (A) either (1) LIBOR
or (2) the higher of the Federal Funds Rate plus 0.5%, the Prime Rate, or LIBOR plus 1.0% and
(B) for the revolving credit facility, a variable margin based on the Companys leverage, or for
the term loan facility, a fixed margin. As part of the 2007 amendments, $175 million of borrowings
under the term loan facility were restricted to using three-month LIBOR in determining their
interest rates. This change was made in connection with interest rate swap agreements executed in
2007. These swap agreements effectively fixed the interest rate through June 2011 on $150 million
of borrowings under the term loan facility. At September 30, 2009, the average interest rate for
revolving credit borrowings was 6.5%, and the effective interest rate for term loan borrowings
after adjusting for the interest rate swaps was 9.1%. At December 31, 2008, the average interest
rate was 2.6% for revolving credit borrowings and 6.5% for term loan borrowings.
We are subject to a number of restrictive covenants under our credit facilities, which could
affect our flexibility to fund ongoing operations and strategic initiatives, and, if we are unable
to maintain compliance with such covenants, could lead to significant challenges in meeting our
liquidity requirements. Continued weak economic conditions could impact our financial performance,
making it more challenging to comply with the financial covenants. At September 30, 2009, we were
in compliance with the covenants of the 2009 Amended Credit Facility.
On October 26, 2009, we amended our 2009 Amended Credit Facility, the effectiveness of which
is conditioned upon, among other things, receipt of gross proceeds of at least $150.0 million from
an offering of common stock. See Note 18, Subsequent Event.
Receivable Sales Programs
We have several programs to sell, on an ongoing basis, pools of our trade accounts receivable.
These programs accelerate cash collections at favorable financing costs and help us manage the
Companys liquidity requirements. The costs associated with these programs were $1.6 million and
$1.4 million for the three months ended September 30, 2009 and 2008, respectively, and $2.4 million
and $5.1 million for the nine months ended September 30, 2009 and 2008, respectively, and are
reported as interest expense.
We have an asset securitization program for substantially all of Ferros U.S. trade accounts
receivable. This program accelerates cash collections at favorable financing costs and helps us
manage the Companys liquidity requirements. In June 2009, we replaced the prior program with a
new program that expires in June 2010 and reduced the programs size from $75 million to
$50 million.
We legally sell these trade accounts receivable to Ferro Finance Corporation (FFC), which
finances its acquisition of trade receivable assets by selling undivided variable percentage
interests in the receivables to certain purchasers under the program. Advances by the purchasers
are secured by, and repaid through collections on, the receivables owned by FFC. FFC and the
purchasers have no recourse to Ferros other assets for failure of payment of the receivables as a
result of the lack of creditworthiness or financial inability to pay of the related obligor. FFC
is a wholly-owned subsidiary, which until December 2008 was a qualified special purpose entity
(QSPE) and, therefore, was not consolidated. In December 2008, FFC ceased to meet the
requirements of a QSPE and is included in our consolidated financial statements. As a result, this
program is now accounted for as an on balance sheet arrangement.
Ferros consolidated balance sheet includes outstanding trade accounts receivable legally
transferred to FFC of $95.3 million at September 30, 2009, and $90.3 million at December 31, 2008,
and short-term debt from advances by the purchasers for their interests in those receivables of
$28.6 million at September 30, 2009, and $-0- at December 31, 2008. After reductions for
non-qualifying receivables, availability under the program was $-0- at September 30, 2009, and
$56.8 million at December 31, 2008.
14
Activity from this program for the nine months ended September 30, 2008, when this program was
accounted for as an off balance sheet arrangement, is detailed below:
|
|
|
|
|
|
|
(Dollars in |
|
|
|
thousands) |
|
Trade accounts receivable sold to FFC |
|
$ |
840,151 |
|
Cash proceeds from FFC |
|
|
840,405 |
|
Trade accounts receivable collected and remitted to FFC and the conduits |
|
|
820,027 |
|
Servicing fees from FFC |
|
|
444 |
|
In addition, we maintain several international programs to sell trade accounts receivable to
financial institutions. The commitments supporting these programs can be withdrawn at any time and
totaled $72.5 million at September 30, 2009, and $81.7 million at December 31, 2008. The amount of
outstanding receivables sold under the international programs was $17.6 million at September 30,
2009, and $30.5 million at December 31, 2008. Ferro had received net proceeds under the
international programs of $13.2 million at September 30, 2009, and $16.7 million at December 31,
2008, for outstanding receivables. Based on available and qualifying receivables, availability
under these programs was $-0- at September 30, 2009, and $26.4 million at December 31, 2008. Ferro
provides normal collection and administration services for the trade accounts receivable sold to
certain financial institutions. Servicing fees are not material.
Activity from these programs for the nine months ended September 30 is detailed below:
|
|
|
|
|
|
|
|
|
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Trade accounts receivable sold to financial institutions |
|
$ |
84,675 |
|
|
$ |
186,054 |
|
Cash proceeds from financial institutions |
|
|
93,853 |
|
|
|
184,628 |
|
Trade accounts receivable collected and remitted to financial institutions
for programs where we provide collection and administrative services |
|
|
27,394 |
|
|
|
60,863 |
|
8. Financial Instruments
The carrying amounts of the following assets and liabilities meeting the definition of a
financial instrument approximate their fair values due to the short period to maturity of the
instruments:
|
|
|
Cash and cash equivalents; |
|
|
|
Miscellaneous receivables; and |
|
|
|
Short-term loans payable to banks. |
Long-term Debt
The following financial instruments are measured at fair value for disclosure purposes. The
carrying values of these instruments may or may not be their fair values.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2009 |
|
|
December 31, 2008 |
|
|
|
Carrying |
|
|
Fair |
|
|
Carrying |
|
|
Fair |
|
|
|
Amount |
|
|
Value |
|
|
Amount |
|
|
Value |
|
|
|
(Dollars in thousands) |
|
$172.5 million 6.50% Convertible Senior Notes |
|
$ |
156,004 |
|
|
$ |
150,705 |
|
|
$ |
153,451 |
|
|
$ |
84,725 |
|
Revolving credit facility |
|
|
131,400 |
|
|
|
126,102 |
|
|
|
111,803 |
|
|
|
88,757 |
|
Term loan facility |
|
|
290,211 |
|
|
|
275,221 |
|
|
|
292,498 |
|
|
|
225,731 |
|
Other notes |
|
|
2,773 |
|
|
|
1,752 |
|
|
|
1,543 |
|
|
|
975 |
|
15
The fair values of the Convertible Notes are based on a third partys estimated bid price.
The fair values of the revolving credit facility, the term loan facility, and the other long-term
notes are based on the present value of expected future cash flows and assumptions about current
interest rates and the creditworthiness of the Company that market participants would use in
pricing the debt.
Derivative Instruments
All derivative instruments are recognized as either assets or liabilities at fair value. For
derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the
derivative is reported as a component of other comprehensive income (OCI) and reclassified from
accumulated other comprehensive income (AOCI) into earnings when the hedged transaction affects
earnings. For derivatives that are not designated as hedges, the gain or loss on the derivative is
recognized in current earnings.
Interest rate swaps. To reduce our exposure to interest rate changes on variable-rate debt,
we entered into interest rate swap agreements in 2007. These swaps effectively converted $150
million of our variable-rate term loan facility to a fixed rate. These swaps are designated and
qualify as cash flow hedges. The fair value of these swaps is based on the present value of
expected future cash flows, which reflects assumptions about current interest rates and the
creditworthiness of the Company that market participants would use in pricing the swaps. The
interest rate swaps were moved to Level 3 within the fair value hierarchy as of the beginning of
the second quarter of 2009 because the assumption about the creditworthiness of the Company was not
an observable market-based input nor an unobservable input that could be corroborated by market
data for sufficiently similar financial instruments. We based our assumption about the
creditworthiness of the Company on the assumption implicit in the bid price of our Convertible
Notes, adjusted by us for differences between these financial instruments in their conversion,
security and liquidity features. The estimated net amount of existing losses at September 30,
2009, that is expected to be recognized in earnings within the next twelve months is $5.4 million.
Foreign currency forward contracts. We manage foreign currency risks principally by entering
into forward contracts to mitigate the impact of currency fluctuations on transactions. These
forward contracts are not formally designated as hedges. The fair value of these contracts is
based on market prices for comparable contracts. We had foreign currency forward contracts with a
notional amount of $190.2 million at September 30, 2009, and $156.8 million at December 31, 2008.
Raw material commodity swaps. We reduce our exposure to changes in the pricing of certain raw
material commodities principally using swap arrangements that allow us to fix the price of a
portion of these commodities that will be purchased during the next twelve months. These swaps are
designated and qualify as cash flow hedges. The fair value of these swaps is based on market
prices for comparable contracts. We had raw material commodity swap arrangements for 75 metric
tons of base metals at September 30, 2009, and 330 metric tons at December 31, 2008. The estimated
net amount of existing gains at September 30, 2009, that is expected to be recognized in earnings
within the next twelve months is not material.
Precious metals forward contracts. We enter into forward purchase arrangements with precious
metals suppliers to completely cover the value of fixed price sales contracts for products with
precious metal content. Most of these agreements are designated as normal purchase contracts,
which are not considered to be derivatives, and had purchase commitments totaling $15.3 million at
September 30, 2009, and $5.5 million at December 31, 2008. Any remaining precious metal contracts
are considered to be derivatives, but are not formally designated as hedges. The fair value of
these precious metal derivatives is based on market prices for comparable contracts. We had no
precious metal derivatives at September 30, 2009, and we had precious metal derivatives for
129 troy ounces at December 31, 2008.
16
The following table presents the fair value of derivative instruments on our consolidated
balance sheets:
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
|
December 31, |
|
|
|
|
|
2009 |
|
|
2008 |
|
|
Balance Sheet Location |
|
|
(Dollars in thousands) |
|
|
|
Derivatives designated as hedging instruments: |
|
|
|
|
|
|
|
|
|
|
Asset derivatives: |
|
|
|
|
|
|
|
|
|
|
Raw material commodity swaps |
|
$ |
42 |
|
|
$ |
|
|
|
Other receivables |
|
|
|
|
|
|
|
|
|
Liability derivatives: |
|
|
|
|
|
|
|
|
|
|
Interest rate swaps |
|
$ |
(10,352 |
) |
|
$ |
(12,724 |
) |
|
Other non-current liabilities |
Raw material commodity swaps |
|
|
|
|
|
|
(576 |
) |
|
Accrued expenses and other current liabilities |
|
|
|
|
|
|
|
|
|
Total fair value |
|
$ |
(10,352 |
) |
|
$ |
(13,300 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives not designated as hedging
instruments: |
|
|
|
|
|
|
|
|
|
|
Asset derivatives: |
|
|
|
|
|
|
|
|
|
|
Foreign currency forward contracts |
|
$ |
|
|
|
$ |
1,621 |
|
|
Other receivables |
Foreign currency forward contracts |
|
|
956 |
|
|
|
230 |
|
|
Accrued expenses and other current liabilities |
Precious metals forward contracts |
|
|
|
|
|
|
8 |
|
|
Other receivables |
|
|
|
|
|
|
|
|
|
Total fair value |
|
$ |
956 |
|
|
$ |
1,859 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liability derivatives: |
|
|
|
|
|
|
|
|
|
|
Foreign currency forward contracts |
|
$ |
|
|
|
$ |
(1,140 |
) |
|
Other receivables |
Foreign currency forward contracts |
|
|
(1,650 |
) |
|
|
(807 |
) |
|
Accrued expenses and other current liabilities |
|
|
|
|
|
|
|
|
|
Total fair value |
|
$ |
(1,650 |
) |
|
$ |
(1,947 |
) |
|
|
|
|
|
|
|
|
|
|
|
17
The inputs to the valuation techniques used to measure fair value are classified into the
following categories:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market-based inputs or unobservable inputs that are corroborated by
market data.
Level 3: Unobservable inputs that are not corroborated by market data.
The carrying amount, fair value, and classification within the fair value hierarchy of these
financial instruments were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2009 |
|
|
December 31, |
|
|
|
Level 1 |
|
|
Level 2 |
|
|
Level 3 |
|
|
Total |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency forward
contracts |
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
480 |
|
Raw material commodity swaps |
|
|
|
|
|
|
42 |
|
|
|
|
|
|
|
42 |
|
|
|
|
|
Precious metals forward contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fair value |
|
$ |
|
|
|
$ |
42 |
|
|
$ |
|
|
|
$ |
42 |
|
|
$ |
488 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swaps |
|
$ |
|
|
|
$ |
|
|
|
$ |
(10,352 |
) |
|
$ |
(10,352 |
) |
|
$ |
(12,724 |
) |
Foreign currency forward
contracts |
|
|
|
|
|
|
(694 |
) |
|
|
|
|
|
|
(694 |
) |
|
|
(576 |
) |
Raw material commodity swaps |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(576 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fair value |
|
$ |
|
|
|
$ |
(694 |
) |
|
$ |
(10,352 |
) |
|
$ |
(11,046 |
) |
|
$ |
(13,876 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A reconciliation of the beginning and ending balances of the financial instruments in Level 3 is as
follows:
|
|
|
|
|
|
|
|
|
|
|
Three |
|
|
Nine |
|
|
|
months ended |
|
|
|
September 30, 2009 |
|
|
|
(Dollars in thousands) |
|
Beginning balance |
|
$ |
(9,425 |
) |
|
$ |
|
|
Total losses included in other comprehensive income |
|
|
(2,827 |
) |
|
|
(1,802 |
) |
Settlements |
|
|
1,900 |
|
|
|
3,544 |
|
Transfers in and/or out of Level 3 |
|
|
|
|
|
|
(12,094 |
) |
|
|
|
|
|
|
|
Ending balance |
|
$ |
(10,352 |
) |
|
$ |
(10,352 |
) |
|
|
|
|
|
|
|
18
The following table presents the effect of derivative instruments on our consolidated
financial performance for the nine months ended September 30:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount of Gain (Loss) |
|
|
|
|
|
|
Amount of Gain (Loss) |
|
|
Reclassified from AOCI |
|
|
Location of Gain (Loss) |
|
|
|
Recognized in OCI |
|
|
into Income |
|
|
Reclassified from |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
AOCI into Income |
|
|
|
(Dollars in thousands) |
|
|
|
|
|
Derivatives in Cash
Flow Hedging
Relationships: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swaps |
|
$ |
(2,708 |
) |
|
$ |
(1,707 |
) |
|
$ |
(5,080 |
) |
|
$ |
(2,415 |
) |
|
Interest expense |
Raw material commodity swaps |
|
|
56 |
|
|
|
(1,681 |
) |
|
|
(1,108 |
) |
|
|
(2,420 |
) |
|
Cost of sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(2,652 |
) |
|
$ |
(3,388 |
) |
|
$ |
(6,188 |
) |
|
$ |
(4,835 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount of Gain (Loss) |
|
|
|
|
|
|
Recognized in Income |
|
|
Location of Gain (Loss) |
|
|
|
2009 |
|
|
2008 |
|
|
in Income |
|
|
|
(Dollars in thousands) |
|
|
|
|
|
Derivatives Not Designated as Hedging
Instruments: |
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency forward contracts |
|
$ |
(12,970 |
) |
|
$ |
2,925 |
|
|
Foreign currency gains (losses), net |
Precious metals forward contracts |
|
|
16 |
|
|
|
1,593 |
|
|
Cost of sales |
Precious metals forward contracts |
|
|
(8 |
) |
|
|
(747 |
) |
|
Miscellaneous income (expense), net |
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
(12,962 |
) |
|
$ |
3,771 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9. Income Taxes
Income tax benefit for the nine months ended September 30, 2009 was $15.8 million, or 36.1 percent of
pre-tax loss, compared with income tax expense of $14.3 million, or 41.7 percent of pre-tax income, in the prior-year nine months
ended September 2008. The primary reason for the decrease in the
effective tax rate was a change
in the mix of income and losses reported by country, partially offset
by an increase to the deferred tax asset for
research credits.
The Company has recorded deferred tax assets of $21.1 million for foreign net operating loss
carryforwards and $45.0 million in credit carryforwards. While some of these assets have an
indefinite expiration date, others will expire in varying amounts between 2011 and 2028.
Realization of these assets is dependent on generating sufficient future taxable income and tax
liabilities to offset the loss and credit carryforwards. Although realization is not assured,
management believes it is more likely than not that all of these deferred tax assets will be
utilized. The amount of these deferred tax assets considered realizable, however, could be
reduced in the near term if estimates of future taxable income are reduced. Additionally, under
Section 382 of the Internal Revenue Code, if a corporation undergoes an ownership change, the
corporations ability to use its pre-change net operating loss carryforwards and other tax
attributes to offset its post-change income may be limited and may result in a partial or full
write down of the related deferred tax assets. An ownership change is defined generally for these
purposes as a greater than 50% change in ownership over a three-year period, taking into account
shareholders that own 5% or more by value of the Companys
common stock. At September 30, 2009, the Company had reached a 40% threshold as calculated under Section 382 of the Internal Revenue
Code. Accordingly, it is possible that
a combination of past and future transactions involving the
Companys common stock will cause an ownership
change to occur that would limit the Companys ability to use its existing net operating loss
carryforwards and other tax attributes. At September 30, 2009, the Companys ability to use these
attributes had not been limited.
The Company conducts business globally, and, as a result, the U.S. parent company and its
subsidiaries file income tax returns in the U.S. federal jurisdiction and various state and foreign
jurisdictions. In the normal course of business, the U.S. parent company and its subsidiaries are
subject to examination by taxing authorities throughout the world. With few exceptions, we are not
subject to federal, state, local or non-U.S. income tax examinations for years before 2000.
19
10. Contingent Liabilities
The Company has been named in six indirect purchaser class action lawsuits seeking monetary
damages and injunctive relief from alleged violations of the antitrust laws by the Company and
others participating in the plastics additives industry. The United States Department of Justice had investigated possible
antitrust violations in the plastics additive industry and closed its investigation without taking
any action against the Company or any of its current or former
employees. The Company was named in two direct purchaser lawsuits
relating to the subject of the Department of Justice investigation,
settled those suits without admitting to any
of the alleged violations, and continues to deny any wrongdoing. The Company intends to vigorously
defend these six remaining indirect purchaser civil actions, which are all in their early stages; therefore, the
Company cannot determine the outcome of these lawsuits at this time.
There are various other lawsuits and claims pending against the Company and its consolidated
subsidiaries. In our opinion, the ultimate liabilities, if any, and expenses resulting from such
lawsuits and claims will not materially affect the consolidated financial position, results of
operations, or cash flows of the Company.
The Company had bank guarantees and standby letters of credit issued by financial
institutions, which totaled $13.1 million at September 30, 2009, and $13.9 million at December 31,
2008. These agreements primarily relate to Ferros insurance programs and foreign tax payments. If
the Company fails to perform its obligations, the guarantees and letters of credit may be drawn
down by their holders, and we would be liable to the financial institutions for the amounts drawn.
11. Retirement Benefits
Information concerning net periodic benefit costs of our U.S. pension plans (including our
unfunded nonqualified plans), non-U.S. pension plans, and postretirement health care and life
insurance benefit plans for the three months ended September 30 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Pension Plans |
|
|
Non-U.S. Pension Plans |
|
|
Other Benefit Plans |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Components of net periodic cost: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost |
|
$ |
7 |
|
|
$ |
50 |
|
|
$ |
1,095 |
|
|
$ |
1,308 |
|
|
$ |
4 |
|
|
$ |
16 |
|
Interest cost |
|
|
5,235 |
|
|
|
5,177 |
|
|
|
2,743 |
|
|
|
2,955 |
|
|
|
719 |
|
|
|
731 |
|
Expected return on plan assets |
|
|
(3,863 |
) |
|
|
(5,663 |
) |
|
|
(1,841 |
) |
|
|
(2,148 |
) |
|
|
|
|
|
|
|
|
Amortization of prior service cost |
|
|
24 |
|
|
|
25 |
|
|
|
(107 |
) |
|
|
29 |
|
|
|
(437 |
) |
|
|
(411 |
) |
Net amortization and deferral |
|
|
3,845 |
|
|
|
624 |
|
|
|
274 |
|
|
|
53 |
|
|
|
|
|
|
|
|
|
Curtailment and settlement effects |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(133 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit cost |
|
$ |
5,248 |
|
|
$ |
213 |
|
|
$ |
2,164 |
|
|
$ |
2,064 |
|
|
$ |
286 |
|
|
$ |
336 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20
Information concerning net periodic benefit costs of our U.S. pension plans (including our
unfunded nonqualified plans), non-U.S. pension plans, and postretirement health care and life
insurance benefit plans for the nine months ended September 30 is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. Pension Plans |
|
|
Non-U.S. Pension Plans |
|
|
Other Benefit Plans |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Components of net periodic cost: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost |
|
$ |
22 |
|
|
$ |
150 |
|
|
$ |
3,143 |
|
|
$ |
4,366 |
|
|
$ |
11 |
|
|
$ |
48 |
|
Interest cost |
|
|
15,707 |
|
|
|
15,531 |
|
|
|
7,839 |
|
|
|
8,934 |
|
|
|
2,158 |
|
|
|
2,193 |
|
Expected return on plan assets |
|
|
(11,590 |
) |
|
|
(16,989 |
) |
|
|
(5,254 |
) |
|
|
(6,484 |
) |
|
|
|
|
|
|
|
|
Amortization of prior service cost |
|
|
73 |
|
|
|
75 |
|
|
|
(305 |
) |
|
|
78 |
|
|
|
(1,311 |
) |
|
|
(1,233 |
) |
Net amortization and deferral |
|
|
11,535 |
|
|
|
1,872 |
|
|
|
780 |
|
|
|
165 |
|
|
|
|
|
|
|
|
|
Curtailment and settlement effects |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(133 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit cost |
|
$ |
15,747 |
|
|
$ |
639 |
|
|
$ |
6,203 |
|
|
$ |
6,926 |
|
|
$ |
858 |
|
|
$ |
1,008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The change in net periodic cost is due primarily to higher amortization of actuarial losses,
which increased substantially last year from the decline in the valuation of plan investments in
the global capital markets. In addition, our expected return on plan assets in 2009 is based on
their lower valuation at December 31, 2008.
12. Stock-Based Compensation
The following table contains the total stock-based compensation expense recorded in selling,
general and administrative expense for the nine months ended September 30:
|
|
|
|
|
|
|
|
|
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Stock options |
|
$ |
1,356 |
|
|
$ |
1,753 |
|
Performance shares |
|
|
35 |
|
|
|
187 |
|
Deferred stock units |
|
|
118 |
|
|
|
411 |
|
Restricted shares |
|
|
371 |
|
|
|
307 |
|
|
|
|
|
|
|
|
Total |
|
$ |
1,880 |
|
|
$ |
2,658 |
|
|
|
|
|
|
|
|
The following table contains information regarding the stock-based compensation as of and for
the nine-month period ended September 30, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aggregate |
|
|
|
|
|
|
|
|
|
|
Weighted- |
|
|
Grant Date |
|
|
Remaining |
|
|
|
Number of |
|
|
Average Fair |
|
|
Fair Value of |
|
|
Service or |
|
|
|
Shares or |
|
|
Value per |
|
|
Shares or |
|
|
Performance |
|
|
|
Units Granted |
|
|
Share or Unit |
|
|
Units Granted |
|
|
Period |
|
|
|
|
|
|
|
|
|
|
|
(Dollars in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
thousands) |
|
|
(In years) |
|
Stock options |
|
|
676,700 |
|
|
$ |
0.49 |
|
|
$ |
335 |
|
|
|
3.5 |
|
Deferred stock units |
|
|
34,200 |
|
|
|
1.33 |
|
|
|
45 |
|
|
|
0.4 |
|
Restricted shares |
|
|
142,100 |
|
|
|
1.37 |
|
|
|
194 |
|
|
|
2.4 |
|
21
The stock-based compensation transaction in shareholders equity consisted of the following
for the nine months ended September 30, 2009:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Shares |
|
|
|
|
|
|
in Treasury |
|
|
Paid-in |
|
|
|
Shares |
|
|
Amount |
|
|
Capital |
|
|
|
(In thousands) |
|
Stock options |
|
|
|
|
|
$ |
|
|
|
$ |
1,356 |
|
Performance shares, net |
|
|
181 |
|
|
|
(594 |
) |
|
|
439 |
|
Deferred stock units |
|
|
(34 |
) |
|
|
835 |
|
|
|
(718 |
) |
Directors deferred compensation |
|
|
|
|
|
|
(757 |
) |
|
|
757 |
|
Preferred stock conversions |
|
|
(1,070 |
) |
|
|
23,394 |
|
|
|
(21,389 |
) |
Restricted shares |
|
|
(115 |
) |
|
|
2,732 |
|
|
|
(2,361 |
) |
|
|
|
|
|
|
|
|
|
|
Total |
|
|
(1,038 |
) |
|
$ |
25,610 |
|
|
$ |
(21,916 |
) |
|
|
|
|
|
|
|
|
|
|
13. Restructuring and Cost Reduction Programs
During the first nine months of 2009, we continued several restructuring programs across a
number of our business segments with the objectives of leveraging our global scale, realigning and
lowering our cost structure and optimizing capacity utilization. The programs are primarily
associated with North America and Europe. Management continues to evaluate our business, and
therefore, there may be supplemental provisions for new plan initiatives as well as changes in
estimates to amounts previously recorded, as payments are made or actions are completed.
To date, we have made substantial progress on the restructuring activities, including exiting
manufacturing facilities and eliminating positions, which resulted in total restructuring charges
of $7.8 million and $23.0 million incurred in the first nine months of 2009 and 2008, respectively,
with $3.9 million and $22.3 million, respectively, included in restructuring charges on the
Condensed Consolidated Statements of Operations and the remaining $3.9 million and $0.7 million,
respectively, recorded in cost of sales as it relates to accelerated depreciation of assets to be
disposed.
The following restructuring programs had significant activities in the first nine months of
2009:
Restructuring Program in Rotterdam, Netherlands
In the second quarter of 2009, a full environmental investigation of the facility was
conducted, and the result of the investigation significantly reduced our assessment of potential
environmental liability by $3.7 million from the amount previously recorded in restructuring
charges in 2007. As a result of this reduction in environmental reserve, a $3.2 million credit to
restructuring charges was recorded at this facility in the first nine months of 2009. Included in
property, plant and equipment is $1.4 million of assets classified as held for sale representing
the building located on this Rotterdam site.
Restructuring Program in Limoges, France
In January 2009, we initiated additional restructuring activities within our Inorganic
Specialties operations in Europe. We plan to discontinue smelting, milling and other manufacturing
operations in Limoges, France. These activities will be consolidated at other Company facilities in
St. Dizier, France; Frankfurt, Germany; Colditz, Germany; and Almazora, Spain. In addition, all
sales, technical service and research and development activities currently being done in Limoges
will be transferred to St. Dizier and Frankfurt. The restructuring action is expected to be
substantially completed at the end of 2010. When the restructuring is completed, the Limoges site
will be closed.
As a result of these restructuring actions, we expect to eliminate approximately 125 employee
positions. We expect to record pre-tax charges of approximately $29 million related to the actions
over the next seven quarters, although the exact timing of the charges cannot be determined at this
time. The expected charges include approximately $18 million in cash costs for employee
termination, approximately $7 million in site cleanup and other costs, and approximately $4 million
of non-cash asset write-offs.
22
As of September 30, 2009, the Limoges restructuring resulted in a workforce reduction of 38
employees. For the nine months ended September 30, 2009, we incurred approximately $6.1 million in
total restructuring charges at this facility, of which $0.4 million were recorded in cost of sales
as it relates to accelerated depreciation of assets to be disposed. The remaining $5.7 million,
primarily for employee severance costs, are included in restructuring charges.
Restructuring Program in Nules, Spain
In June 2009, we initiated additional restructuring activities at our Inorganic Specialty
operation in Nules, Spain, and suspended the production of tile coatings at this site, with
production consolidated at our facility in Almazora, Spain. As a result of the restructuring
actions, we expect to eliminate 35 positions. We expect to record pre-tax charges of approximately
$5.7 million. For the nine months ended September 30, 2009, we incurred $3.8 million in total
restructuring charges at this facility, with $3.3 million recorded in cost of sales as it relates
to accelerated depreciation of assets to be disposed. As of September 30, 2009, the restructuring
activity resulted in a workforce reduction of seven employees, and the associated severance costs
incurred were not material. The remaining $0.5 million, primarily for other costs, are included in
restructuring charges.
Restructuring Program in Penn Yan, New York
In April 2009, we initiated additional restructuring activities within our Electronic
Materials operation in Penn Yan, New York. The program is associated with planned elimination of
some Multi-Layer Ceramic Capacitor (MLCC) research and testing capability in Penn Yan. As of
September 30, 2009, the Penn Yan restructuring resulted in a workforce reduction of 13 employees,
and we incurred costs of $0.4 million, primarily for employee severance.
Other Restructuring Programs
There have been no significant changes in remaining restructuring programs. In the first nine
months of 2009, the charges from these programs totaled $0.5 million, primarily for additional
severance and other costs.
We have summarized the activities and accruals related to our restructuring and cost reduction
programs below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee |
|
|
|
|
|
|
|
|
|
Termination |
|
|
Other |
|
|
|
|
|
|
Benefits |
|
|
Costs |
|
|
Total |
|
|
|
(Dollars in thousands) |
|
Balance at December 31, 2008 |
|
$ |
1,206 |
|
|
$ |
5,102 |
|
|
$ |
6,308 |
|
Restructuring charges |
|
|
5,222 |
|
|
|
(1,291 |
) |
|
|
3,931 |
|
Cash payments |
|
|
(6,194 |
) |
|
|
(2,470 |
) |
|
|
(8,664 |
) |
Currency translation adjustment |
|
|
(66 |
) |
|
|
229 |
|
|
|
163 |
|
Non-cash items |
|
|
5 |
|
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
Balance at September 30, 2009 |
|
$ |
173 |
|
|
$ |
1,570 |
|
|
$ |
1,743 |
|
|
|
|
|
|
|
|
|
|
|
We expect to make cash payments to settle the remaining liability for employee termination
benefits and other costs primarily over the next twelve months, except where legal or contractual
restrictions prevent us from doing so.
23
14. Discontinued Operations
In the fourth quarter of 2008, we sold our Fine Chemicals business. The following operations
of the Fine Chemicals business for the three and nine months ended September 30, 2008, were removed
from continuing operations and included in discontinued operations in the Companys Condensed
Consolidated Statements of Operations.
|
|
|
|
|
|
|
|
|
|
|
Three |
|
|
Nine |
|
|
|
months ended |
|
|
|
September 30, 2008 |
|
|
|
(Dollars in thousands) |
|
Net sales |
|
$ |
18,438 |
|
|
$ |
53,276 |
|
Cost of sales |
|
|
14,770 |
|
|
|
41,144 |
|
|
|
|
|
|
|
|
Gross profit |
|
|
3,668 |
|
|
|
12,132 |
|
Selling, general and administrative expenses |
|
|
1,332 |
|
|
|
3,880 |
|
Other expense: |
|
|
|
|
|
|
|
|
Interest expense |
|
|
422 |
|
|
|
1,342 |
|
Foreign currency transactions, net |
|
|
13 |
|
|
|
13 |
|
Miscellaneous expense, net |
|
|
41 |
|
|
|
41 |
|
|
|
|
|
|
|
|
Income from discontinued operations before income taxes |
|
|
1,860 |
|
|
|
6,856 |
|
Income tax expense |
|
|
601 |
|
|
|
2,270 |
|
|
|
|
|
|
|
|
Income from discontinued operations, net of income taxes |
|
$ |
1,259 |
|
|
$ |
4,586 |
|
|
|
|
|
|
|
|
Gain (loss) on disposal of discontinued operations consists of adjustments to the gross
proceeds, net assets sold or transaction costs related to the sale of the Fine Chemicals business
and residual legal and environmental costs directly related to the Powder Coatings, Petroleum
Additives and Specialty Ceramics businesses, which were sold in 2002 and 2003.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
Nine months ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Gain (loss) on disposal of discontinued operations
before income tax expense (benefit) |
|
$ |
63 |
|
|
$ |
(94 |
) |
|
$ |
(519 |
) |
|
$ |
(120 |
) |
Income tax expense (benefit) |
|
|
27 |
|
|
|
(37 |
) |
|
|
(197 |
) |
|
|
(47 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain (loss) on disposal of discontinued operations,
net of income tax expense (benefit) |
|
$ |
36 |
|
|
$ |
(57 |
) |
|
$ |
(322 |
) |
|
$ |
(73 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
We have continuing environmental remediation obligations that are related to these
divestitures, and we had accrued $2.9 million at September 30, 2009, and $3.0 million at December
31, 2008, for these matters.
24
15. Per Share Amounts from Continuing Operations
Details of the calculation of basic and diluted earnings (loss) per share are shown below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
Nine months ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(In thousands, |
|
|
|
except per share amounts) |
|
Basic earnings (loss) per share computation: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to Ferro Corporation
common shareholders |
|
$ |
1,949 |
|
|
$ |
4,385 |
|
|
$ |
(30,564 |
) |
|
$ |
22,440 |
|
Adjustment for (income) loss from discontinued
operations |
|
|
(36 |
) |
|
|
(1,202 |
) |
|
|
322 |
|
|
|
(4,513 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,913 |
|
|
$ |
3,183 |
|
|
$ |
(30,242 |
) |
|
$ |
17,927 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding |
|
|
44,711 |
|
|
|
43,636 |
|
|
|
44,593 |
|
|
|
43,638 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings (loss) per share from continuing
operations
attributable to Ferro Corporation common shareholders |
|
$ |
0.04 |
|
|
$ |
0.07 |
|
|
$ |
(0.68 |
) |
|
$ |
0.41 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per share computation: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) attributable to Ferro Corporation
common shareholders |
|
$ |
1,949 |
|
|
$ |
4,385 |
|
|
$ |
(30,564 |
) |
|
$ |
22,440 |
|
Adjustment for (income) loss from discontinued
operations |
|
|
(36 |
) |
|
|
(1,202 |
) |
|
|
322 |
|
|
|
(4,513 |
) |
Plus: Convertible preferred stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
1,913 |
|
|
$ |
3,183 |
|
|
$ |
(30,242 |
) |
|
$ |
17,927 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average common shares outstanding |
|
|
44,711 |
|
|
|
43,636 |
|
|
|
44,593 |
|
|
|
43,638 |
|
Assumed exercise of stock options |
|
|
265 |
|
|
|
161 |
|
|
|
|
|
|
|
|
|
Assumed satisfaction of deferred stock unit conditions |
|
|
20 |
|
|
|
20 |
|
|
|
|
|
|
|
11 |
|
Assumed conversion of convertible notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assumed conversion of convertible preferred stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average diluted shares outstanding |
|
|
44,996 |
|
|
|
43,817 |
|
|
|
44,593 |
|
|
|
43,649 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings (loss) per share from continuing
operations
attributable to Ferro Corporation common shareholders |
|
$ |
0.04 |
|
|
$ |
0.07 |
|
|
$ |
(0.68 |
) |
|
$ |
0.41 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25
16. Comprehensive Income (Loss)
The components of comprehensive income (loss) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
Nine months ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Net income (loss) |
|
$ |
2,845 |
|
|
$ |
5,058 |
|
|
$ |
(28,314 |
) |
|
$ |
24,501 |
|
Other comprehensive income (loss), net of tax: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign currency translation adjustments |
|
|
12,567 |
|
|
|
(36,255 |
) |
|
|
17,540 |
|
|
|
(14,724 |
) |
Postretirement benefit liability adjustments |
|
|
(498 |
) |
|
|
3,090 |
|
|
|
163 |
|
|
|
2,676 |
|
Raw material commodity swap adjustments |
|
|
18 |
|
|
|
(1 |
) |
|
|
577 |
|
|
|
454 |
|
Interest rate swap adjustments |
|
|
(598 |
) |
|
|
(150 |
) |
|
|
1,527 |
|
|
|
456 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income (loss) |
|
|
14,334 |
|
|
|
(28,258 |
) |
|
|
(8,507 |
) |
|
|
13,363 |
|
Less: Comprehensive income attributable to
noncontrolling interests |
|
|
731 |
|
|
|
454 |
|
|
|
1,711 |
|
|
|
1,676 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive income (loss) attributable to
Ferro Corporation |
|
$ |
13,603 |
|
|
$ |
(28,712 |
) |
|
$ |
(10,218 |
) |
|
$ |
11,687 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17. Reporting for Segments
The Company has six reportable segments: Performance Coatings, Electronic Materials, Color and
Glass Performance Materials, Polymer Additives, Specialty Plastics and Pharmaceuticals. We have
combined our Tile Coating Systems and
Porcelain Enamel business units into one reportable segment, Performance Coatings, because of
their similar economic and operating characteristics.
The accounting policies of our segments are consistent with those described for our
consolidated financial statements in the summary of significant accounting policies contained in
our Annual Report on Form 10-K for the year ended December 31, 2008. We measure segment income for
internal reporting purposes as income from continuing operations before unallocated corporate
expenses, impairment charges, restructuring charges, other expense (income) items, such as interest
expense, and income tax expense. Unallocated corporate expenses primarily consist of corporate
employment costs and professional services.
Net sales to external customers by segment are presented in the table below. Sales between
segments were not material.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
Nine months ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Performance Coatings |
|
$ |
129,499 |
|
|
$ |
162,523 |
|
|
$ |
355,420 |
|
|
$ |
501,819 |
|
Electronic Materials |
|
|
113,210 |
|
|
|
155,122 |
|
|
|
296,269 |
|
|
|
452,317 |
|
Color and Glass Performance Materials |
|
|
88,498 |
|
|
|
115,013 |
|
|
|
232,264 |
|
|
|
374,083 |
|
Polymer Additives |
|
|
67,660 |
|
|
|
93,081 |
|
|
|
190,105 |
|
|
|
284,107 |
|
Specialty Plastics |
|
|
39,040 |
|
|
|
58,097 |
|
|
|
110,833 |
|
|
|
183,499 |
|
Pharmaceuticals |
|
|
4,182 |
|
|
|
6,314 |
|
|
|
14,284 |
|
|
|
17,139 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net sales |
|
$ |
442,089 |
|
|
$ |
590,150 |
|
|
$ |
1,199,175 |
|
|
$ |
1,812,964 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
26
Below are each segments income (loss) and reconciliations to income (loss) before taxes from
continuing operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
Nine months ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
Performance Coatings |
|
$ |
14,518 |
|
|
$ |
12,135 |
|
|
$ |
20,144 |
|
|
$ |
34,400 |
|
Electronic Materials |
|
|
13,129 |
|
|
|
17,095 |
|
|
|
21,933 |
|
|
|
43,527 |
|
Color and Glass Performance Materials |
|
|
7,815 |
|
|
|
9,712 |
|
|
|
7,583 |
|
|
|
40,695 |
|
Polymer Additives |
|
|
4,386 |
|
|
|
4,385 |
|
|
|
7,863 |
|
|
|
11,703 |
|
Specialty Plastics |
|
|
2,977 |
|
|
|
2,796 |
|
|
|
7,148 |
|
|
|
7,520 |
|
Pharmaceuticals |
|
|
(1,316 |
) |
|
|
656 |
|
|
|
(989 |
) |
|
|
199 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total segment income |
|
|
41,509 |
|
|
|
46,779 |
|
|
|
63,682 |
|
|
|
138,044 |
|
Unallocated corporate expenses |
|
|
14,258 |
|
|
|
13,379 |
|
|
|
46,564 |
|
|
|
33,705 |
|
Impairment charges |
|
|
8,225 |
|
|
|
|
|
|
|
8,225 |
|
|
|
|
|
Restructuring charges |
|
|
2,842 |
|
|
|
9,042 |
|
|
|
3,931 |
|
|
|
22,280 |
|
Interest expense |
|
|
17,891 |
|
|
|
12,424 |
|
|
|
46,255 |
|
|
|
38,747 |
|
Other expense, net |
|
|
(767 |
) |
|
|
7,202 |
|
|
|
2,543 |
|
|
|
9,034 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income before income taxes from
continuing operations |
|
$ |
(940 |
) |
|
$ |
4,732 |
|
|
$ |
(43,836 |
) |
|
$ |
34,278 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
We sell our products throughout the world, and we attribute sales to countries based on the
country where we generate the customer invoice. We have detailed net sales by geographic region in
the table below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
Nine months ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
2009 |
|
|
2008 |
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands) |
|
United States |
|
$ |
198,521 |
|
|
$ |
270,541 |
|
|
$ |
549,538 |
|
|
$ |
777,036 |
|
Spain |
|
|
66,249 |
|
|
|
90,459 |
|
|
|
188,465 |
|
|
|
290,353 |
|
Other international |
|
|
177,319 |
|
|
|
229,150 |
|
|
|
461,172 |
|
|
|
745,575 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total net sales |
|
$ |
442,089 |
|
|
$ |
590,150 |
|
|
$ |
1,199,175 |
|
|
$ |
1,812,964 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
18. Subsequent Event
On October 26, 2009, we amended and restated our 2009 Amended Credit Facility. The effectiveness of the amendment
and restatement is conditioned, among other things, upon our receipt of at least $150.0 million in gross proceeds from
an offering of common stock. The 2009 Amended Credit Facility, as amended and restated, extends the maturity of the
revolving commitments through June 6, 2012. Pursuant to the 2009 Amended Credit Facility, as amended and restated,
$100 million of revolving loans are being converted into new term loans that also mature on June 6, 2012. The new term
loans will have terms substantially similar to the existing term loans.
In addition, the amendment and restatement of the 2009 Amended Credit Facility will: modify the maximum permitted
leverage ratio; modify the minimum permitted fixed charge coverage ratio; delete the minimum EBITDA covenant; require
application of the net proceeds from the equity offering in excess of $50 million to repay outstanding term loans;
modify our obligations to apply the net proceeds of dispositions to repay outstanding revolving and term loans; step
down the portion of the annual excess cash flow required to be used to repay outstanding loans depending on the
leverage ratio; increase the amount of indebtedness our foreign subsidiaries may incur based on the leverage ratio;
allow payment of dividends to holders of Series A preferred shares; eliminate the cap on the amount of cash we may
deliver to secure our obligations arising under our precious metals program; and limit the amount of cash or cash
equivalents we may hold.
27
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
Overview
Customer demand improved in the three months ended September 30, 2009, compared with the first
and second quarters of 2009, but demand continued to be lower than in the third quarter of 2008.
Our customers inventory reductions appear to have moderated, which contributed to our sequential
sales increases during the third quarter.
Net sales declined by 25.1 percent in the three months ended September 30, 2009, compared with
the prior-year period. Net sales increased 10.7 percent, sequentially, compared with the second
quarter of 2009. Compared with the prior-year period, sales declined in all segments and in all
regions as a result of the worldwide economic downturn. The primary driver of the sales decline was
lower sales volume, including reduced sales of precious metals. Lower precious metals sales
contributed approximately 3 percentage points to the overall net sales decline. Lower product
prices and changes in product mix accounted for approximately 6 percentage points of the sales
decline during the quarter. Product prices moved lower in the quarter generally in line with lower
raw material costs. Changes in foreign currency exchange rates were responsible for approximately 1
percentage point of the sales decline.
The cost of raw materials and energy declined in the quarter, in aggregate, compared with raw
material and energy costs in the prior-year period. Reductions in product prices offset much of the
benefit of lower raw material costs and contributed to the lower net sales for the quarter.
Selling, general and administrative (SG&A) expense declined as a result of initiatives to
reduce staffing and lower spending that were taken in response to our reduced sales levels. An
increase in pension expense partially offset the expense reduction initiatives.
We recorded an $8.2 million impairment of goodwill related to our Pharmaceuticals business
during the third quarter. The impairment was triggered by changes made to the assumptions used to
determine valuation under the market approach.
Restructuring charges were recorded in the quarter, primarily related to manufacturing
rationalization activities in Europe and other cost reduction activities. Restructuring charges
were lower than in the prior-year period.
Interest expense increased during the third quarter of 2009 compared with the prior-year
period primarily as a result of higher average borrowing levels and higher interest rates. The
requirement to provide cash collateral for precious metal leases was a major contributor to the
increased borrowing levels. As a result of an amendment to our credit facilities that was signed in
March 2009, the interest rates on our term loans and revolving credit borrowings have increased,
contributing to the higher interest expense.
We recorded a loss from continuing operations in the 2009 third quarter primarily as a result
of restructuring and impairment charges. In addition, lower net sales during the quarter resulted
in reduced gross profit that was only partially offset by lower SG&A expense. Also contributing to
the loss was the increase in interest expense during the 2009 third quarter.
During 2008, we sold our Fine Chemicals business. Results related to our Fine Chemicals
business, which had previously been combined with the results from our Pharmaceuticals business and
reported as Other Businesses, are now reported as discontinued operations for all periods
presented.
Outlook
General economic conditions around the world deteriorated sharply in the final two months of
2008 and the difficult economic conditions have continued during 2009. Demand for our products is
driven by a number of end-use applications including residential and commercial building and
renovation, electronics, appliances, automobiles and automotive parts, and containers. These
industries have experienced substantial contractions since late 2008. In addition, weak end-market
demand contributed to our customers decisions to reduce inventory, which further reduced sales of
our products. In aggregate,
demand for our products has improved since the first quarter of 2009, and is expected to
improve modestly in future quarters. However, worldwide economic conditions are expected to remain
challenging.
28
In the near term, we expect relatively flat worldwide demand in our targeted end-use
applications and positive, but temporary, impact from government stimulus programs. Our visibility
to future demand for our products is limited, as our customers production plans are uncertain and
subject to rapid adjustment to unanticipated changes in sales of their products. Our customers may
choose to reduce their inventory levels during the fourth quarter, which would negatively impact
our sales in the period. Because we have limited order lead times from our customers, customer
orders are not a reliable indicator of our future results.
Our responses to the worldwide economic downturn have included restructuring initiatives to
lower manufacturing costs, reduced manufacturing staffing and reduced working hours to adjust
production resources to the decline in customer demand, lower discretionary expense spending,
reduced incentive compensation and suspension of other employee benefits, lower capital spending,
and elimination of our common stock dividends. We expect to continue to record charges associated
with our current and future restructuring programs, as we proceed with initiatives to rationalize
our manufacturing operations in Europe, align our worldwide operations to reduced customer demand
and take action to lower SG&A expense.
Factors that could adversely affect our future financial performance are described under the
heading Risk Factors in Item 1A of Part I of our Annual Report on Form 10-K for the year ended
December 31, 2008.
Results of Operations
Comparison of the three months ended September 30, 2009 and 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
|
|
|
|
|
|
|
September 30, |
|
|
|
|
|
|
|
|
|
2009 |
|
|
2008 |
|
|
$ Change |
|
|
% Change |
|
|
|
(Dollars in thousands, |
|
|
|
|
|
|
|
except per share amounts) |
|
|
|
|
|
Net sales |
|
$ |
442,089 |
|
|
$ |
590,150 |
|
|
$ |
(148,061 |
) |
|
|
(25.1 |
%) |
Cost of sales |
|
|
348,920 |
|
|
|
479,807 |
|
|
|
(130,887 |
) |
|
|
(27.3 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
93,169 |
|
|
|
110,343 |
|
|
|
(17,174 |
) |
|
|
(15.6 |
%) |
Gross profit percentage |
|
|
21.1 |
% |
|
|
18.7 |
% |
|
|
|
|
|
|
|
|
Selling, general and administrative expenses |
|
|
65,918 |
|
|
|
76,943 |
|
|
|
(11,025 |
) |
|
|
(14.3 |
%) |
Impairment charges |
|
|
8,225 |
|
|
|
|
|
|
|
8,225 |
|
|
|
|
|
Restructuring charges |
|
|
2,842 |
|
|
|
9,042 |
|
|
|
(6,200 |
) |
|
|
(68.6 |
%) |
Other expense (income): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
17,891 |
|
|
|
12,424 |
|
|
|
5,467 |
|
|
|
44.0 |
% |
Interest earned |
|
|
(216 |
) |
|
|
(213 |
) |
|
|
(3 |
) |
|
|
1.4 |
% |
Loss on extinguishment of debt |
|
|
|
|
|
|
5,531 |
|
|
|
(5,531 |
) |
|
|
100.0 |
% |
Foreign currency losses, net |
|
|
104 |
|
|
|
1,647 |
|
|
|
(1,543 |
) |
|
|
(93.7 |
%) |
Miscellaneous (income) expense, net |
|
|
(655 |
) |
|
|
237 |
|
|
|
(892 |
) |
|
|
(376.4 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income before income taxes |
|
|
(940 |
) |
|
|
4,732 |
|
|
|
(5,672 |
) |
|
|
(119.9 |
%) |
Income tax (benefit) expense |
|
|
(3,749 |
) |
|
|
876 |
|
|
|
(4,625 |
) |
|
|
(528.0 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations |
|
|
2,809 |
|
|
|
3,856 |
|
|
|
(1,047 |
) |
|
|
(27.2 |
%) |
Income from discontinued operations, including disposal,
net of income tax |
|
|
36 |
|
|
|
1,202 |
|
|
|
(1,166 |
) |
|
|
(97.0 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income |
|
$ |
2,845 |
|
|
$ |
5,058 |
|
|
$ |
(2,213 |
) |
|
|
(43.8 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share |
|
$ |
0.04 |
|
|
$ |
0.10 |
|
|
$ |
(0.06 |
) |
|
|
(60.0 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29
Net sales in the three months ended September 30, 2009, declined primarily as a result of
lower sales volume due to the global economic downturn and the resulting lower customer demand.
Lower sales volume accounted for approximately 17 percentage points of the overall sales decline
and changes in product mix and prices accounted for approximately 6 percentage points of the
decline. These factors include reduced sales of precious metals. Lower precious metal sales
contributed approximately 3 percentage points to the lower sales. Changes in foreign currency
exchange rates were responsible for approximately 1 percentage point of the third-quarter sales
decline. Sales declined in all segments and in all regions compared with the prior-year period.
Gross profit was lower in the 2009 third quarter compared with the 2008 third quarter as a
result of the decline in net sales. Cost reduction initiatives, including staffing reductions,
plant closures and restructuring actions, partially offset the decline in gross profit. Gross
margin percentage increased compared with the prior-year period as a result of the cost reduction
initiatives. Raw material costs declined by approximately $26 million compared with the 2008 third
quarter. The benefit from lower raw material costs was largely offset by lower product prices.
Charges primarily related to manufacturing rationalization activities reduced gross profit by
approximately $0.3 million during the 2009 third quarter. Gross profit was reduced by approximately
$1.5 million in the third quarter of 2008 as a result of charges associated with manufacturing
rationalization and asset write-offs.
Selling, general and administrative (SG&A) expense declined by $11.0 million in the quarter
ended September 30, 2009, compared with the prior-year period. SG&A expense was 14.9 percent of
sales in the quarter compared with 13.0 percent during the 2008 third quarter due to lower sales.
SG&A expense declined as a result of expense reduction efforts we made in response to weak customer
demand. The expense reductions included reduced staffing, lower incentive compensation expense and
reduced discretionary spending. These actions contributed to a reduction of approximately $7.5
million in salary and wage expense and a $2.4 million reduction in travel and entertainment expense
compared with the prior-year period. Partially offsetting these declines was an increase of
approximately $5.0 million in pension expense. SG&A expense during the quarter included charges of
approximately $2.7 million primarily related to expense reduction initiatives. The 2008
third-quarter SG&A expense included charges of approximately $1.9 million primarily related to
corporate development activities, partially offset by a favorable insurance settlement.
We recorded impairment charges of $8.2 million during the third quarter related to a reduction
in goodwill associated with our pharmaceutical business. The impairment was triggered by changes
made to the assumptions used to determine valuation under the market approach.
Restructuring charges declined to $2.8 million in the third quarter of 2009 from $9.0 million
in the third quarter of 2008. In the period, the restructuring charges were primarily related to
manufacturing rationalization activities in our European inorganic materials operations and other
cost-reduction actions.
Interest expense increased during the 2009 third quarter compared with the prior-year period.
Interest expense increased approximately $3.7 million due to higher interest rates primarily
resulting from an amendment to our credit facilities that we signed in March 2009 and approximately
$0.8 million due to increased borrowings. Additional changes in interest expense resulted from
differences in the amortization of fees and discounts. A primary driver of the increased borrowing
levels was a requirement to provide cash collateral for precious metal leases. As of September 30,
2009, we had $92.3 million of cash on deposit as collateral for precious metals.
During the 2008 third quarter, we refinanced our 9 1/8% coupon senior notes using the proceeds
of a new convertible bond issue and additional borrowing from our revolving credit facility. In
connection with the repayment of the previous senior notes, we recorded a loss on extinguishment of
debt of $5.5 million. This loss did not recur in the 2009 third quarter.
Net foreign currency transaction losses were $0.1 million during the 2009 third quarter
compared with losses of $1.6 million in the 2008 third quarter. We manage currency translation
risks in a wide variety of foreign currencies principally by entering into forward contracts to
mitigate the impact of currency fluctuations on transactions arising from international trade. The
carrying values of these contracts are adjusted to market value and the resulting gains and losses
are charged to income or expense in the period.
The income tax benefit for the three months ended September 30, 2009 was $3.7 million, or 400 percent
of pre-tax loss, compared with income tax expense of $0.9 million, or 18.5 percent of pre-tax income, in
the 2008 third quarter. The primary
reason for the significant improvement in the effective rate was due to an increase in the
deferred tax asset for research credits.
30
The 2009 third quarter loss from operations was primarily the result of lower net sales
and the consequent reduction in gross profit, the impairment charge for goodwill in our
pharmaceutical business and higher interest expense. Reduced SG&A expense and lower restructuring
charges combined to reduce the loss from operations.
During 2008, we sold the Fine Chemicals business, which was previously part of our Other
Businesses segment. As a consequence of the sale, the results from Fine Chemicals are now included
in discontinued operations for all periods presented.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
|
|
|
|
|
|
|
September 30, |
|
|
|
|
|
|
|
|
|
2009 |
|
|
2008 |
|
|
$ Change |
|
|
% Change |
|
|
|
(Dollars in thousands) |
|
|
|
|
Segment Sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance Coatings |
|
$ |
129,499 |
|
|
$ |
162,523 |
|
|
$ |
(33,024 |
) |
|
|
(20.3 |
%) |
Electronic Materials |
|
|
113,210 |
|
|
|
155,122 |
|
|
|
(41,912 |
) |
|
|
(27.0 |
%) |
Color & Glass Performance Materials |
|
|
88,498 |
|
|
|
115,013 |
|
|
|
(26,515 |
) |
|
|
(23.1 |
%) |
Polymer Additives |
|
|
67,660 |
|
|
|
93,081 |
|
|
|
(25,421 |
) |
|
|
(27.3 |
%) |
Specialty Plastics |
|
|
39,040 |
|
|
|
58,097 |
|
|
|
(19,057 |
) |
|
|
(32.8 |
%) |
Pharmaceuticals |
|
|
4,182 |
|
|
|
6,314 |
|
|
|
(2,132 |
) |
|
|
(33.8 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total segment sales |
|
$ |
442,089 |
|
|
$ |
590,150 |
|
|
$ |
(148,061 |
) |
|
|
(25.1 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Operating Income (Loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance Coatings |
|
$ |
14,518 |
|
|
$ |
12,135 |
|
|
$ |
2,383 |
|
|
|
19.6 |
% |
Electronic Materials |
|
|
13,129 |
|
|
|
17,095 |
|
|
|
(3,966 |
) |
|
|
(23.2 |
%) |
Color & Glass Performance Materials |
|
|
7,815 |
|
|
|
9,712 |
|
|
|
(1,897 |
) |
|
|
(19.5 |
%) |
Polymer Additives |
|
|
4,386 |
|
|
|
4,385 |
|
|
|
1 |
|
|
|
0.0 |
% |
Specialty Plastics |
|
|
2,977 |
|
|
|
2,796 |
|
|
|
181 |
|
|
|
6.5 |
% |
Pharmaceuticals |
|
|
(1,316 |
) |
|
|
656 |
|
|
|
(1,972 |
) |
|
|
(300.6 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total segment operating income |
|
$ |
41,509 |
|
|
$ |
46,779 |
|
|
$ |
(5,270 |
) |
|
|
(11.3 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance Coatings Segment Results. Sales declined in Performance Coatings primarily as a
result of lower volumes of tile coatings, partially offset by modestly higher sales volume of
porcelain enamel products. The decline in net volume was responsible for approximately $20 million
of the reduction in sales, while changes in product prices and mix reduced sales by approximately
$6.6 million and changes in foreign currency exchange rates contributed approximately $6.1 million
to the sales decline. The sales decline was the largest in Europe, our largest market for these
products, and sales also declined in the United States. Operating income increased due to a
reduction in SG&A expense of $4.0 million, which more than offset a decline in gross profit of $1.6
million. The decline in SG&A expense was due to staffing reductions and expense control
initiatives. The decline in gross profit was due to the negative effects of lower sales volume of
tile products partially offset by increased gross profit from porcelain enamel products and lower
manufacturing costs.
Electronic Materials Segment Results. Sales declined in Electronic Materials as a result of
lower sales volume, primarily related to reduced demand for dielectric materials that are used by
our customers to make capacitors. Sales of conductive metal pastes and powders and surface
finishing products also declined compared with the prior-year period. A decline in sales of
precious metals contributed approximately $18.8 million, or
slightly less than half of the overall sales
reduction, reflecting both price and volume changes. Our sales of precious metals fluctuate with
both the volume of product sold and the price of precious metals. The costs of precious metals
included in our product sales are generally passed through to customers with minimal gross profit
contribution. Operating income declined due to a $9.0 million decrease in gross profit partially
offset by a reduction of $5.0 million in SG&A expense. The decline in gross profit was primarily
due to the negative effects of lower
sales volumes. The decline in SG&A expense was due to expense control initiatives, including
the elimination of incentive compensation and staffing reductions.
31
Color and Glass Performance Materials Segment Results. Sales of Color and Glass Performance
Materials declined as a result of lower sales volume. Approximately $16.9 million of the reduction
in sales during the third quarter was the result of lower sales volume. The remaining reduction in
sales was due to a $7.3 million unfavorable change in product mix and pricing and a $2.2 million
negative effect from foreign currency exchanges rates. All regions contributed to the sales
decline. Operating income declined due to a $5.6 million decline in gross profit, partially offset
by a $3.7 million reduction in SG&A expense. The decline in gross profit was primarily due to the
negative effects of lower sales volumes. The reduction in SG&A expense was primarily due to
staffing reductions and expense control initiatives.
Polymer Additives Segment Results. Sales declined in Polymer Additives primarily as a result
of lower sales volume and changes in product pricing in the United States and Europe. The reduction
in volume accounted for approximately $13.2 million of the reduction in sales, while changes in
product pricing and mix contributed approximately $11.2 million to the sales decline. Operating
profit was flat compared with the prior-year period as a decline of $1.4 million in gross profit
was matched by a $1.4 million reduction in SG&A expense. The decline in gross profit was due to the
negative effects of lower sales volumes partially offset by lower manufacturing costs. The decline
in SG&A expense was due to staffing reductions and expense control initiatives.
Specialty Plastics Segment Results. Sales declined in Specialty Plastics primarily as a result
of lower sales volume. Approximately $14.1 million of the reduction in sales during the third
quarter was the result of lower sales volume and the remaining reduction was primarily driven by a
$4.3 million unfavorable change in product pricing and mix. Operating income increased compared
with the prior-year period as a $1.9 million reduction in SG&A expense more than offset a $1.7
million decline in gross profit. The reduction in SG&A expense was due to staffing reductions and
expense control initiatives. The decline in gross profit was due to the negative effects of lower
sales volumes partially offset by improved manufacturing cost performance.
Pharmaceuticals Segment Results. Sales declined in Pharmaceuticals primarily as a result of
changes in product mix. An operating loss was recorded during the third quarter, compared with an
operating profit in the prior-year period primarily due to a $2.6 million decline in gross profit,
which was partially offset by a $0.6 million reduction in SG&A expense. The decline in gross profit
was primarily due to product mix changes. The decline in SG&A expense was primarily due to expense
control initiatives. Results related to our Fine Chemicals business, which had previously been
combined with the results from our Pharmaceuticals business and reported as Other Businesses, are
now reported as discontinued operations following the sale of the Fine Chemicals business in 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
|
|
|
|
|
|
|
September 30, |
|
|
|
|
|
|
|
|
|
2009 |
|
|
2008 |
|
|
$ Change |
|
|
% Change |
|
|
|
(Dollars in thousands) |
|
|
|
|
Geographic Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
$ |
198,521 |
|
|
$ |
270,541 |
|
|
$ |
(72,020 |
) |
|
|
(26.6 |
%) |
International |
|
|
243,568 |
|
|
|
319,609 |
|
|
|
(76,041 |
) |
|
|
(23.8 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
442,089 |
|
|
$ |
590,150 |
|
|
$ |
(148,061 |
) |
|
|
(25.1 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the third quarter, international sales were approximately 55 percent of total net sales.
Compared with the prior-year period, sales declined in all regions due to reduced customer demand
resulting from the global economic downturn. Also contributing to the sales decline were reduced
sales of precious metals and changes in foreign currency exchange rates.
32
Comparison of the nine months ended September 30, 2009 and 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended |
|
|
|
|
|
|
|
|
|
September 30, |
|
|
|
|
|
|
|
|
|
2009 |
|
|
2008 |
|
|
$ Change |
|
|
% Change |
|
|
|
(Dollars in thousands, |
|
|
|
|
|
|
except per share amounts) |
|
|
|
|
Net sales |
|
$ |
1,199,175 |
|
|
$ |
1,812,964 |
|
|
$ |
(613,789 |
) |
|
|
(33.9 |
%) |
Cost of sales |
|
|
985,531 |
|
|
|
1,474,382 |
|
|
|
(488,851 |
) |
|
|
(33.2 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
213,644 |
|
|
|
338,582 |
|
|
|
(124,938 |
) |
|
|
(36.9 |
%) |
Gross profit percentage |
|
|
17.8 |
% |
|
|
18.7 |
% |
|
|
|
|
|
|
|
|
Selling, general and administrative expenses |
|
|
196,526 |
|
|
|
234,243 |
|
|
|
(37,717 |
) |
|
|
(16.1 |
%) |
Impairment charges |
|
|
8,225 |
|
|
|
|
|
|
|
8,225 |
|
|
|
|
|
Restructuring charges |
|
|
3,931 |
|
|
|
22,280 |
|
|
|
(18,349 |
) |
|
|
(82.4 |
%) |
Other expense (income): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
46,255 |
|
|
|
38,747 |
|
|
|
7,508 |
|
|
|
19.4 |
% |
Interest earned |
|
|
(689 |
) |
|
|
(484 |
) |
|
|
(205 |
) |
|
|
42.4 |
% |
Loss on extinguishment of debt |
|
|
|
|
|
|
5,531 |
|
|
|
(5,531 |
) |
|
|
(100.0 |
%) |
Foreign currency losses (gains), net |
|
|
3,033 |
|
|
|
756 |
|
|
|
2,277 |
|
|
|
301.2 |
% |
Miscellaneous expense, net |
|
|
199 |
|
|
|
3,231 |
|
|
|
(3,032 |
) |
|
|
(93.8 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income before income taxes |
|
|
(43,836 |
) |
|
|
34,278 |
|
|
|
(78,114 |
) |
|
|
(227.9 |
%) |
Income tax (benefit) expense |
|
|
(15,844 |
) |
|
|
14,290 |
|
|
|
(30,134 |
) |
|
|
(210.9 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income from continuing operations |
|
|
(27,992 |
) |
|
|
19,988 |
|
|
|
(47,980 |
) |
|
|
(240.0 |
%) |
(Loss) income from discontinued operations, including disposal,
net of income tax |
|
|
(322 |
) |
|
|
4,513 |
|
|
|
(4,835 |
) |
|
|
(107.1 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income |
|
$ |
(28,314 |
) |
|
$ |
24,501 |
|
|
$ |
(52,815 |
) |
|
|
(215.6 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted (loss) earnings per share |
|
$ |
(0.69 |
) |
|
$ |
0.51 |
|
|
$ |
(1.20 |
) |
|
|
(235.3 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales for the nine months ended September 30, 2009, declined by 34 percent compared to the
corresponding prior-year period primarily as a result of lower sales volume as our customers
responded to the economic downturn. Lower sales volume accounted for approximately 27 percentage
points of the overall sales decline. Changes in product mix and prices accounted for approximately
4 percentage points of the decline. These factors include reduced sales of precious metals. Lower
precious metal sales contributed approximately 6 percentage points to the lower sales. Changes in
foreign currency exchange rates were responsible for approximately 3 percent of the sales decline.
Sales declined in all segments and all regions.
Gross profit declined in the first nine months of 2009 compared with the prior-year period
primarily as a result of reduced sales. Reduced cost of sales resulting from cost reduction
actions, including staffing reductions, plant closures and other restructuring actions, moderated
the decline in gross profit. Raw material costs also declined compared with the first half of
2008; however, the benefit from lower raw material costs was largely offset by lower product
prices. Gross profit for the first nine months of 2009 was reduced by charges of $3.9 million
primarily related to accelerated depreciation and other costs of manufacturing rationalization.
Gross profit in the first nine months of 2008 was reduced by approximately $3.0 million related to
charges for asset write-offs and manufacturing rationalization activities. Also, gross profit in
the prior-year period was reduced by costs of approximately $3.3 million to clean up an accidental
discharge of product into the wastewater treatment facility at our Bridgeport, New Jersey,
manufacturing location.
Selling, general and administrative (SG&A) expense declined by $37.7 million during the
first nine months of 2009 compared with the same period in 2008. The decline in SG&A expense was
driven by expense reduction efforts including reduced staffing, lower incentive compensation
expense and suspension of other employee benefits, a furlough program for certain salaried
employees and containment of discretionary spending. These actions contributed to a reduction of
approximately $28.8 million in salary and wage expense and a $9.4 million reduction in travel
and entertainment expense compared with the prior-year period. Partially offsetting these expense
reductions was an increase of approximately $15.1 million in pension expense that resulted from a
reduction in the value of pension assets in 2008. SG&A expense for the first nine months of 2009
included approximately $7.0 million of charges related to expense reduction initiatives and
manufacturing rationalization activities. SG&A expense in the first nine months of 2008 included
charges of approximately $3.8 million primarily related to corporate development activities, asset
write-offs and employee severance expenses, partially offset by benefits from litigation
settlements and insurance proceeds.
33
During the first nine months of 2009 we recorded impairment charges of $8.2 million related to
a reduction of goodwill associated with our Pharmaceutical business. The impairment was triggered
by changes made to the assumptions used to determine valuation under the market approach.
Restructuring charges declined to $3.9 million in the first three quarters of 2009 from $22.3
million in the prior-year period. In 2009, the restructuring charges were primarily related to
manufacturing rationalization activities in our European inorganic materials operations and other
cost-reduction actions. Partially offsetting these charges was a benefit of approximately $3.7
million resulting from a reduction of an environmental reserve related to a closed manufacturing
site in Europe. The restructuring charges during the first three quarters of 2008 were primarily
related to manufacturing rationalization activities in our Performance Coatings and Color and Glass
Performance Materials manufacturing operations in Europe and Brazil, and additional restructuring
activities in our Performance Coatings, Color and Glass Performance Materials, Polymer Additives,
and Specialty Plastics segments.
Interest expense increased during the first nine months of 2009 compared with the prior-year
period. Interest expense increased approximately $5.2 million due to higher interest rates
primarily resulting from an amendment to our credit facilities that we signed in March 2009 and
approximately $2.5 million due to increased borrowings. Additional changes in interest expense
resulted from differences in the amortization of fees and discounts and changes in foreign funding
programs. A primary driver of the increased borrowing levels was a requirement to provide cash
collateral for precious metal leases. As of September 30, 2009, we had $92.3 million of cash on
deposit as collateral for precious metals.
During the first nine months of 2008, we refinanced our 9 1/8% coupon senior notes using the
proceeds of a new convertible note issue and additional borrowing from our revolving credit
facility. In connection with the repayment of the previous senior notes, we recorded a loss on
extinguishment of debt of $5.5 million. This loss did not recur in 2009.
Net foreign currency transaction losses were $3.0 million during the first nine months of 2009
compared with losses of $0.8 million in prior-year period. We manage currency translation risks in
a wide variety of foreign currencies principally by entering into forward contracts to mitigate the
impact of currency fluctuations on transactions arising from international trade. The carrying
values of these contracts are adjusted to market value and the resulting gains and losses are
charged to income or expense in the period.
The income tax benefit for the nine months ended September 30, 2009, was $15.8 million, or
36.1 percent of pre-tax loss, compared with income tax expense of $14.3 million, or 41.7 percent of pre-tax income, in the nine months
ended September 30, 2008. The primary reason for the decrease in
the effective rate was a change
in the mix of income and losses reported by country, partially offset
by an increase in the deferred tax asset for
research credits.
The loss from continuing operations in the first nine months of 2009 was the result of reduced
sales volume and the related reduction in gross profit, an impairment of goodwill and higher
interest expense. Partially offsetting these items were reduced SG&A expense, lower restructuring
charges and the absence of a loss on extinguishment of debt.
During 2008, we sold the Fine Chemicals business, which was previously part of our Other
Businesses segment. The results from Fine Chemicals are now included in discontinued operations for
all periods.
34
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended |
|
|
|
|
|
|
|
|
|
September 30, |
|
|
|
|
|
|
|
|
|
2009 |
|
|
2008 |
|
|
$ Change |
|
|
% Change |
|
|
|
(Dollars in thousands) |
|
|
|
|
Segment Sales |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance Coatings |
|
$ |
355,420 |
|
|
$ |
501,819 |
|
|
$ |
(146,399 |
) |
|
|
(29.2 |
%) |
Electronic Materials |
|
|
296,269 |
|
|
|
452,317 |
|
|
|
(156,048 |
) |
|
|
(34.5 |
%) |
Color & Glass Performance Materials |
|
|
232,264 |
|
|
|
374,083 |
|
|
|
(141,819 |
) |
|
|
(37.9 |
%) |
Polymer Additives |
|
|
190,105 |
|
|
|
284,107 |
|
|
|
(94,002 |
) |
|
|
(33.1 |
%) |
Specialty Plastics |
|
|
110,833 |
|
|
|
183,499 |
|
|
|
(72,666 |
) |
|
|
(39.6 |
%) |
Pharmaceuticals |
|
|
14,284 |
|
|
|
17,139 |
|
|
|
(2,855 |
) |
|
|
(16.7 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total segment sales |
|
$ |
1,199,175 |
|
|
$ |
1,812,964 |
|
|
$ |
(613,789 |
) |
|
|
(33.9 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Operating Income (Loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance Coatings |
|
$ |
20,144 |
|
|
$ |
34,400 |
|
|
$ |
(14,256 |
) |
|
|
(41.4 |
%) |
Electronic Materials |
|
|
21,933 |
|
|
|
43,527 |
|
|
|
(21,594 |
) |
|
|
(49.6 |
%) |
Color & Glass Performance Materials |
|
|
7,583 |
|
|
|
40,695 |
|
|
|
(33,112 |
) |
|
|
(81.4 |
%) |
Polymer Additives |
|
|
7,863 |
|
|
|
11,703 |
|
|
|
(3,840 |
) |
|
|
(32.8 |
%) |
Specialty Plastics |
|
|
7,148 |
|
|
|
7,520 |
|
|
|
(372 |
) |
|
|
(4.9 |
%) |
Pharmaceuticals |
|
|
(989 |
) |
|
|
199 |
|
|
|
(1,188 |
) |
|
|
(597.0 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total segment operating income |
|
$ |
63,682 |
|
|
$ |
138,044 |
|
|
$ |
(74,362 |
) |
|
|
(53.9 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Performance Coatings Segment Results. Sales declined in Performance Coatings as a result of
lower sales volume of tile and porcelain enamel products. Lower sales volume accounted for
approximately $99.4 million of the overall sales decline. Changes in foreign currency exchange
rates contributed approximately $27.0 million of the sales decline and changes in product mix and
price accounted for the rest of the decline. The sales decline was driven by reduced customer
demand in Europe, our largest market for Performance Coatings products, although sales in all
regions were lower during the first nine months of 2009. Operating income declined due to a $33.7
million decline in gross profit that was partially offset by a $19.4 million reduction in SG&A
expense. The decline in gross profit was due to the negative effects of lower sales volumes
partially offset by lower manufacturing costs. The decline in SG&A expense was primarily due to
staffing reductions and tight control of discretionary expense.
Electronic Materials Segment Results. Sales declined in Electronic Materials as a result of a
decline in precious metal sales and lower sales volume, particularly related to reduced demand for
dielectric materials that are used by our customers to make capacitors. Sales of conductive metal
pastes and powders and surface finishing products also declined compared with the prior-year
period. The decline in precious metal sales accounted for $89.9 million of the overall
sales decline for the segment. Our sales of precious metals fluctuate with both the volume of
products we sell and the price of precious metals. The costs of precious metals that are included
in our product sales are generally passed through to customers with minimal gross profit
contribution. Operating income declined, compared with the prior-year period, as a result of a
$32.7 million reduction in gross profit partially offset by an $11.1 million reduction in SG&A
expense. The decline in gross profit was primarily due to the negative effects of lower sales
volumes. The reduction in SG&A expense was primarily due to expense control initiatives, including
the elimination of incentive compensation.
Color and Glass Performance Materials Segment Results. Sales of Color and Glass Performance
Materials declined as a result of lower sales volume. Approximately $97.7 million of the reduction
in sales during the first nine months of 2009 was the result of lower sales volume. An additional
$28.8 million of the sales reduction was due to changes in product mix and price, with the
remaining change in sales primarily resulting from changes in foreign currency exchange rates. All
regions contributed to the sales decline. Operating income declined from the prior-year period as a
result of a $46.5 million reduction in gross profit partially offset by a $13.4 million decline in
SG&A expense. The decline in gross profit was the result of the negative effects of lower sales
volumes partially offset by improved manufacturing cost performance. The reduction in SG&A expense
was primarily the result of staffing reductions and expense control initiatives.
35
Polymer Additives Segment Results. Sales declined in Polymer Additives during the first nine
months of 2009 primarily due to lower sales volume and changes in product pricing in the United
States and Europe. The reduction in volume accounted for approximately $66.6 million of the
reduction in segment sales. Changes in product pricing, primarily the result of lower raw material
costs, also reduced sales by approximately $21.5 million. Operating profit declined as a result of
a $10.0 million reduction in gross profit partially offset by a $6.2 million reduction in SG&A
expense. The decline in gross profit was due to the negative effects of lower sales volume
partially offset by lower manufacturing costs. The decline in SG&A expense was due to staffing
reductions and expense control initiatives.
Specialty Plastics Segment Results. Sales declined in Specialty Plastics primarily as a result
of lower sales volume in the United States and Europe. Lower sales volume accounted for
approximately $63.4 million of the decline in overall segment sales. Operating income declined
slightly as a $6.8 million decline in gross profit was nearly
matched by a $6.4 million reduction
in SG&A expense. The reduction in gross profit was primarily due to the negative effects of lower
sales volumes. The reduction in SG&A expense was driven by staffing reductions and expense control
initiatives.
Pharmaceuticals Segment Results. Sales declined in Pharmaceuticals primarily as a result of
changes in product mix. An operating loss was recorded during the first nine months of the year
compared with income in the prior-year period primarily due to a $2.9 million reduction in gross
profit caused by the change in product mix, partially offset by a $1.7 million decline in SG&A
expense. Results related to our Fine Chemicals business, which previously had been combined with
the results from our Pharmaceuticals business and reported as Other Businesses, are now reported
as discontinued operations following the sale of the Fine Chemicals business in 2008.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended |
|
|
|
|
|
|
|
|
|
September 30, |
|
|
|
|
|
|
|
|
|
2009 |
|
|
2008 |
|
|
$ Change |
|
|
% Change |
|
|
|
(Dollars in thousands) |
|
|
|
|
Geographic Revenues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
|
$ |
549,538 |
|
|
$ |
777,036 |
|
|
$ |
(227,498 |
) |
|
|
(29.3 |
%) |
International |
|
|
649,637 |
|
|
|
1,035,928 |
|
|
|
(386,291 |
) |
|
|
(37.3 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
1,199,175 |
|
|
$ |
1,812,964 |
|
|
$ |
(613,789 |
) |
|
|
(33.9 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the first three quarters of 2009, international sales were approximately 54 percent of
total net sales. Compared with the prior-year period, sales declined in all regions due to reduced
customer demand resulting from the global economic downturn. Also contributing to the sales decline
were reduced sales of precious metals and changes in foreign currency exchange rates.
Summary of Cash Flows for the nine months ended September 30, 2009 and 2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine months ended |
|
|
|
|
|
|
|
|
|
September 30, |
|
|
|
|
|
|
|
|
|
2009 |
|
|
2008 |
|
|
$ Change |
|
|
% Change |
|
|
|
(Dollars in thousands) |
|
|
|
|
Net cash (used for) provided by
operating activities |
|
$ |
(5,769 |
) |
|
$ |
1,838 |
|
|
$ |
(7,607 |
) |
|
|
(413.9 |
%) |
Net cash used for investing activities |
|
|
(30,431 |
) |
|
|
(54,283 |
) |
|
|
23,852 |
|
|
|
(43.9 |
%) |
Net cash provided by financing activities |
|
|
37,183 |
|
|
|
55,359 |
|
|
|
(18,176 |
) |
|
|
(32.8 |
%) |
Effect of exchange rate changes on cash
and cash equivalents |
|
|
3,097 |
|
|
|
(415 |
) |
|
|
3,512 |
|
|
|
(846.3 |
%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increase in cash and cash equivalents |
|
$ |
4,080 |
|
|
$ |
2,499 |
|
|
$ |
1,581 |
|
|
|
63.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
36
Cash flows from operating activities decreased by $7.6 million in the first nine months of
2009 compared with the prior-year period. In the first nine months of 2009, we funded $92.3 million
of deposits required by financial institutions under our precious metals program. Cash flows from
operating activities were also affected by the $52.8 million decrease in net income. Partially
offsetting these effects was an increase of $123.5 million in cash provided by changes in inventory
levels.
Within investing activities, we reduced capital expenditures to $30.7 million in the first
nine months of 2009 from $51.8 million in the first nine months of 2008.
Cash flows from financing activities decreased by $18.2 million, of which $32.4 million
related to borrowing activity. The first nine months of 2009 also included $9.4 million of debt
issuance costs related to an amendment of our revolving credit and term loan facility and a new
domestic accounts receivable asset securitization program, while the first nine months of 2008
included $5.5 million of debt issuance costs related to the Convertible Notes. Partially offsetting
these effects were higher dividend payments in the first nine months of 2008 of $18.9 million
Capital Resources and Liquidity
6.50% Convertible Senior Notes
In 2008, Ferro issued $172.5 million of 6.50% Convertible Senior Notes due 2013 (the
Convertible Notes). The proceeds from the offering, along with available cash, including
borrowings under Ferros revolving credit facility, were used to purchase all of Ferros
outstanding 9 1/8% Senior Notes due 2009. The Convertible Notes bear interest at a rate of 6.5% per
year, payable semi-annually in arrears on February 15 and August 15 of each year, beginning on
February 15, 2009. The Convertible Notes mature on August 15, 2013. We separately account for the
liability and equity components of the Convertible Notes in a manner that will reflect our
nonconvertible debt borrowing rate when interest cost is recognized in subsequent periods. The
effective interest rate on the liability component is 9.5%. At September 30, 2009, we were in
compliance with the covenants under the Convertible Notes indenture.
Revolving Credit and Term Loan Facility
In 2006, we entered into an agreement with a group of lenders for a $700 million credit
facility, consisting of a multi-currency senior revolving credit facility and a senior term loan
facility, which replaced a former revolving credit facility that would have expired later that
year. In 2007, we cancelled the unused portion of the term loan facility and amended the credit
facility (the 2007 Amended Credit Facility) primarily to increase the size of the revolving
credit facility, reduce interest rates, and increase operating flexibility. On March 11, 2009, we
amended the 2007 Amended Credit Facility (the 2009 Amended Credit Facility) primarily to provide
additional operating flexibility and to change pricing to more accurately reflect current market
interest rates. The amendment was filed as Exhibit 10.1 to our Annual Report on Form 10-K for the
year ended December 31, 2008. The primary effects of the 2009 Amended Credit Facility were to:
|
|
|
Increase the interest rates and commitment fees payable thereunder pursuant to a
grid structure based on our leverage ratio, |
|
|
|
|
Increase the maximum permitted quarterly leverage ratio and decrease the minimum
permitted quarterly fixed charge coverage ratio, |
|
|
|
|
Add a minimum cumulative EBITDA requirement for each quarter in 2009, |
|
|
|
|
Restrict the Companys ability to engage in acquisitions and make investments, |
|
|
|
|
Limit the amount of cash and cash equivalent collateral the Company is permitted
to deliver to participants in our precious metals program to secure our obligations arising
under the precious metals consignment agreements, |
|
|
|
|
Require additional financial reporting by the Company to the lenders, |
|
|
|
|
Increase the amount of the annual excess cash flow required to be used to repay
term loans, |
|
|
|
|
Require application of the net proceeds of certain dispositions, but excluding the
first $20 million of such net proceeds, to be applied to repay debt outstanding under the
revolving credit facility and term loans and to permanently reduce availability under the
revolving loan facility on a dollar for dollar basis, provided that we are not required to
reduce the commitments under the revolving credit facility to below $150 million, |
37
|
|
|
Eliminate our ability to request an increase of $50 million in the revolving
credit facility, |
|
|
|
|
Add provisions governing the obligations of the Company and the lenders if one or
more lenders under the revolving credit facility fails to satisfy its funding obligations
or otherwise becomes a defaulting lender, and |
|
|
|
|
Restrict our ability to make payments with respect to our capital securities. The
2009 Amended Credit Facility effectively prohibits us from paying dividends on our
preferred and common stock beginning in the second quarter of 2009. |
The 2009 Amended Credit Facility currently includes a $300.0 million revolving credit
facility, which matures in 2011. At September 30, 2009, we had borrowed $131.4 million of the
revolver and had $161.7 million available, after reductions for standby letters of credit secured
by this facility. At December 31, 2008, we had borrowed $111.8 million of the revolver and had
$180.0 million available. The increase in borrowings under our revolver was driven by our decision,
as discussed below, to cash collateralize certain precious metals consignment agreements.
At September 30, 2009, the 2009 Amended Credit Facility also included a term loan facility
with an outstanding principal balance of $290.2 million, which matures in 2012. We make periodic
principal payments on the term loans. We are required to make minimum quarterly principal payments
of $0.8 million from October 2009 to July 2011. During the last year of the loans life, we are
required to repay the remaining balance of the term loans in four quarterly installments.
Currently, those last four payments will be $71.0 million each. In addition to the minimum
quarterly payments, each April we may be required to make an additional principal payment. The
amount of this additional payment is dependent on the Companys leverage and certain cash flow
metrics. Any additional payment that is required reduces, on a dollar-for-dollar basis, the amount
due in the last four quarterly payments. We were not required to make an additional principal
payment in April 2009.
We are subject to a number of restrictive covenants under our revolving credit and term loan
facilities, which could affect our flexibility to fund ongoing operations and strategic
initiatives, and, if we are unable to maintain compliance with such covenants, could lead to
significant challenges in meeting our liquidity requirements. This risk is described in more detail
in Risk Factors under Item 1A of our Annual Report on Form 10-K for the year ended December 31,
2008. Continued weak economic conditions could impact our financial performance, making it more
challenging to comply with the financial covenants. At September 30, 2009, we were in compliance
with the covenants of the 2009 Amended Credit Facility.
These covenants are negotiated with the group of lenders. The covenants include requirements
for a minimum quarterly cumulative Earnings Before Interest, Taxes, Depreciation, and Amortization,
adjusted for certain noncash charges and restructuring charges up to certain limits (Adjusted
EBITDA), a minimum fixed charge coverage ratio, and a maximum leverage ratio. Definitions of the
covenants and our required performance can be found in the credit agreement and its amendments,
each of which we have previously filed with the Securities and Exchange Commission. The minimum
Adjusted EBITDA covenant expires on January 1, 2010. Our ability to meet these covenants is
primarily driven by our net income before interest, income taxes, depreciation and amortization;
our total debt; and our interest payments. Our total debt is primarily driven by cash flow items,
including net income before amortization, depreciation, and other noncash charges; our capital
expenditures; requirements for deposits from participants in our precious metals program; our
customers ability to make payments for purchases and the timing of such payments; and our ability
to manage inventory and other working capital items. Our interest payments are driven by our total
debt and external fees and interest rates, primarily prime and LIBOR.
On October 26, 2009, we amended and restated our 2009 Amended Credit Facility. The effectiveness of the amendment
and restatement is conditioned, among other things, upon our receipt of at least $150.0 million in gross proceeds from
an offering of common stock. The 2009 Amended Credit Facility, as amended and restated, extends the maturity of the
revolving commitments through June 6, 2012. Pursuant to the 2009 Amended Credit Facility, as amended and restated,
$100 million of revolving loans are being converted into new term loans that also mature on June 6, 2012. The new term
loans will have terms substantially similar to the existing term loans.
38
In addition, the amendment and restatement of the 2009 Amended Credit Facility will: modify the maximum permitted
leverage ratio; modify the minimum permitted fixed charge coverage ratio; delete the minimum EBITDA covenant; require
application of the net proceeds from the equity offering in excess of $50 million to repay outstanding term loans;
modify our obligations to apply the net proceeds of dispositions to repay outstanding revolving and term loans; step
down the portion of the annual excess cash flow required to be used to repay outstanding loans depending on the
leverage ratio; increase the amount of indebtedness our foreign subsidiaries may incur based on the leverage ratio;
allow payment of dividends to holders of Series A preferred shares; eliminate the cap on the amount of cash we may
deliver to secure our obligations arising under our precious metals program; and limit the amount of cash or cash
equivalents we may hold.
Domestic Receivable Sales Program
We have an asset securitization program for substantially all of Ferros U.S. trade accounts
receivable. This program accelerates cash collections at favorable financing costs and helps us
manage the Companys liquidity requirements. In June 2009, we replaced the prior program with a new
program that expires in June 2010 and reduced the programs size from $75 million to $50 million.
We legally sell these trade accounts receivable to Ferro Finance Corporation (FFC), which
finances its acquisition of trade receivable assets by selling undivided variable percentage
interests in the receivables to certain purchasers under the program. Advances by the purchasers
are secured by, and repaid through collections on, the receivables owned by FFC. FFC and the
purchasers have no recourse to Ferros other assets for failure of payment of the receivables as a
result of the lack of creditworthiness or financial inability to pay of the related obligor. FFC is
a wholly-owned subsidiary, which until December 2008 was a qualified special purpose entity
(QSPE) and, therefore, was not consolidated. In December 2008, FFC ceased to meet the
requirements of a QSPE and is included in our consolidated financial statements. As a result, this
program is now accounted for as an on balance sheet arrangement.
At September 30, 2009, Ferros consolidated balance sheet includes outstanding trade accounts
receivable legally transferred to FFC of $95.3 million and short-term debt from advances by the
purchasers for their interests in those receivables of $28.6 million. After reductions for
non-qualifying receivables, there was no additional availability under the program at September 30,
2009.
Off Balance Sheet Arrangements
International Receivable Sales Programs. We maintain several international programs to sell
trade accounts receivable. At September 30, 2009, the commitments supporting these programs, which
can be withdrawn at any time, totaled $72.5 million, the amount of outstanding receivables sold
under these programs was $17.6 million, and Ferro had received net proceeds under these programs of
$13.2 million for outstanding receivables. Based on available and qualifying receivables, there was
no additional availability under these programs at September 30, 2009.
Consignment and Customer Arrangements for Precious Metals. In the production of some of our
products, we use precious metals, primarily silver for Electronic Materials products and gold for
Color and Glass Performance Materials products. We obtain most precious metals from financial
institutions under consignment agreements (generally referred to as our precious metals program).
The financial institutions retain ownership of the precious metals and charge us fees based on the
amounts we consign. These fees were $0.9 million and $3.4 million for the three and nine months
ended September 30, 2009, respectively. At September 30, 2009, we had on hand $82.0 million of
precious metals, measured at fair value, owned by participants in our precious metals program. We
also process precious metals owned by our customers.
The consignment agreements involve short-term commitments that typically mature within 30 to
180 days of each transaction and are typically renewed on an ongoing basis. As a result, the
Company relies on the continued willingness of
financial institutions to participate in these arrangements to maintain this source of
liquidity. During the first half of 2009, participants in our precious metals program required
Ferro to deliver cash collateral to secure Ferros obligations arising under the consignment
agreements. At September 30, 2009, Ferro had delivered $92.3 million in cash collateral to induce
those financial institutions to continue participating in Ferros precious metals program.
39
As participants in our precious metals program require cash collateral to secure our
obligations, Ferro may choose to provide such collateral or purchase the precious metal outright as
an alternative to continuing the consignment arrangements. This requires us to borrow under our
revolving credit facility or raise funds from other financing sources. Such borrowings reduce our
liquidity and increase our borrowing costs. The 2009 Amended Credit Facility prohibits Ferro from
delivering cash and cash equivalent collateral in excess of $120 million to participants in our
precious metals program. Accordingly, Ferro would be required to purchase precious metals outright
if these participants were unwilling to deliver metals in quantities sufficient to meet the
Companys operating requirements without exceeding the cash collateral limits set forth in the
credit facility. Ferro is pursuing a variety of initiatives intended to reduce the amount of
precious metals required to support our manufacturing operations and reduce our dependence on
consignment agreements.
Bank Guarantees and Standby Letters of Credit. At September 30, 2009, the Company and its
subsidiaries had bank guarantees and standby letters of credit issued by financial institutions,
which totaled $13.1 million. These agreements primarily relate to Ferros insurance programs and
foreign tax payments.
Other Financing Arrangements
We maintain other lines of credit to provide global flexibility for Ferros short-term
liquidity requirements. These facilities are uncommitted lines for our international operations and
totaled $19.4 million at September 30, 2009. The available portions of these lines provided $12.5
million of additional liquidity at September 30, 2009.
Liquidity Requirement
Our liquidity requirements primarily include debt service, purchase commitments, labor costs,
working capital requirements, restructuring expenditures, capital investments, precious metals cash
collateral requirements, and postretirement obligations. We expect to meet these requirements in
the long-term through cash provided by operating activities and availability under replacement
credit facilities or other financing arrangements. Cash flows from operating activities are
primarily driven by earnings before noncash charges and changes in working capital needs. In 2009,
capital expenditures and requirements for deposits from participants in our precious metals program
were funded by a net increase in our borrowings under existing credit facilities and by reductions
in certain working capital items, particularly inventory. We have already provided collateral for
substantially all precious metals under consignment; however the value of the consigned materials
and our required collateral will vary with the price of the metals and the quantity of metals used
in our manufacturing operations, which may result in a further use of our liquidity resources. To
enhance liquidity, we have taken actions that include reducing capital spending and suspending
dividend payments.
In the near term, should we continue to use cash for operating activities, we would use
availability under existing credit facilities and further adjust our operations to conserve cash
through restructuring activities that lower manufacturing costs, reduce staffing, lower
discretionary spending, and lower capital spending. These actions could impact our operating
flexibility and ability to achieve operating objectives.
Our level of debt, debt service requirements, and ability to access credit markets could have important
consequences to our business operations and uses of cash flows. The credit shortage in the global capital markets has
not prohibited us from accessing the capital markets, but it has increased our cost of borrowing. The Company issued
the 6.50% Convertible Senior Notes in the third quarter of 2008, amended its Revolving Credit and Term Loan Facility in
the first quarter of 2009, and replaced its expiring asset securitization facility in the second quarter of 2009. In
addition, financial market conditions and access to credit has improved over the last quarter, evidenced by the number
of financing transactions consummated in the credit markets and the pricing of these offerings.
On October 26, 2009, we amended and restated our 2009 Amended Credit Facility. The effectiveness of the amendment
and restatement is conditioned, among other things, upon our receipt of at least $150.0 million in gross proceeds from
an offering of common stock There can be no assurance that we will be able to successfully complete a common stock
offering with sufficient gross proceeds such that the amendment and restatement of our 2009 Amended Credit Facility
will become effective.
40
Recent difficulties experienced in global capital markets could affect the ability or
willingness of counterparties to perform under our various lines of credit, receivable sales
programs, forward contracts, and precious metal lease programs. These counterparties are major,
reputable, multinational institutions, all having investment-grade credit ratings except for one,
which is not rated. Accordingly, we do not anticipate counterparty default. However, an
interruption in access to external financing could adversely affect our business prospects and
financial condition.
We assess on an ongoing basis our portfolio of businesses, as well as our financial and
capital structure, to ensure that we have sufficient capital and liquidity to meet our strategic
objectives. As part of this process, from time to time we evaluate the possible divestiture of
businesses that are not critical to our core strategic objectives and, where appropriate, pursue
the sale of such businesses. We also evaluate and pursue acquisition opportunities that we believe
will enhance our strategic position. We generally announce publicly divestiture and acquisition
transactions only when we have entered into definitive agreements relating to those transactions.
Critical Accounting Policies and Their Application
There are no material changes to our critical accounting policies described in Critical
Accounting Policies within Item 7 of the Companys Annual Report on Form 10-K for the year ended
December 31, 2008.
Newly Issued Accounting Pronouncements
In June 2009, the Financial Accounting Standards Board (FASB) issued Statement No. 166,
Accounting for Transfers of Financial Assets an amendment of FASB Statement No. 140, (FAS No.
166). This pronouncement amends guidance in ASC Topic 860, Transfers
and Servicing for derecognition of transferred financial assets. FAS No. 166 is effective for
financial asset transfers occurring after the beginning of our fiscal year that begins January 1,
2010. Early adoption of FAS No. 166 is prohibited. We are evaluating the impact that the adoption
of FAS No. 166 may have on our consolidated financial statements.
In June 2009, the FASB issued Statement No. 167, Amendments to FASB Interpretation No. 46(R),
(FAS No. 167). This pronouncement amends the consolidation guidance
that applies to variable interest entities (VIEs). FAS No. 167 is effective for our fiscal year
that begins January 1, 2010, and early adoption is prohibited. We are evaluating the impact that
the adoption of FAS No. 167 may have on our consolidated financial statements.
Risk Factors
Certain statements contained here and in future filings with the SEC reflect the Companys
expectations with respect to future performance and constitute forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. These statements are subject to a variety of
uncertainties, unknown risks and other factors concerning the Companys operations and business
environment, which are difficult to predict and are beyond the control of the Company. Factors that
could adversely affect our future financial performance are described under the heading Risk
Factors in Item 1A of Part I of our Annual Report on Form 10-K for the year ended December 31,
2008.
41
Item 3. Quantitative and Qualitative Disclosures About Market Risk
The primary objective of the following information is to provide forward-looking quantitative
and qualitative information about our exposure to instruments that are sensitive to fluctuations in
interest rates, foreign currency exchange rates, and costs of raw materials and energy.
Our exposure to interest rate risk arises from our debt portfolio. We manage this risk by
controlling the mix of fixed versus variable-rate debt after considering the interest rate
environment and expected future cash flows. To reduce our exposure to interest rate changes on
variable-rate debt, we entered into interest rate swap agreements. These swaps effectively convert
a portion of our variable-rate debt to a fixed rate. Our objective is to limit variability in
earnings, cash flows and overall borrowing costs caused by changes in interest rates, while
preserving operating flexibility.
We operate internationally and enter into transactions denominated in foreign currencies.
These transactions expose us to gains and losses arising from exchange rate movements between the
dates foreign currencies are recorded and the dates they are settled. We manage this risk by
entering into forward currency contracts that offset these gains and losses.
We are also subject to cost changes with respect to our raw materials and energy purchases. We
attempt to mitigate raw materials cost increases through product development, price increases, and
other productivity improvements. We hedge a portion of our exposure to changes in the pricing of
certain raw material commodities through swap arrangements that allow us to fix the pricing of the
commodities for future purchases. We also enter into forward purchase arrangements with precious
metals suppliers to completely cover the value of the precious metals content of fixed price sales
contracts. Most of these agreements are designated as normal purchase contracts, which are not
marked to market, and had purchase commitments totaling $15.3 million at September 30, 2009. In
addition, we purchase portions of our natural gas and electricity requirements under fixed price
contracts to reduce the volatility of these costs. These energy contracts are designated as normal
purchase contracts, are not marked to market, and had purchase commitments totaling $10.9 million
at September 30, 2009.
42
The notional amounts, net carrying amounts of assets (liabilities), and fair values associated
with our exposure to these market risks and sensitivity analyses about potential gains (losses)
resulting from hypothetical changes in market rates are presented below:
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
|
December 31, |
|
|
|
2009 |
|
|
2008 |
|
|
|
(Dollars in thousands, |
|
|
|
except as noted) |
|
Variable-rate debt and utilization of accounts receivable sales
programs: |
|
|
|
|
|
|
|
|
Change in annual interest expense from 1% change in interest rates |
|
$ |
3,188 |
|
|
$ |
2,742 |
|
Fixed-rate debt: |
|
|
|
|
|
|
|
|
Carrying amount |
|
$ |
158,777 |
|
|
$ |
154,995 |
|
Fair value |
|
$ |
152,457 |
|
|
$ |
85,700 |
|
Change in fair value from 1% increase in interest rate |
|
$ |
(4,902 |
) |
|
$ |
(2,877 |
) |
Change in fair value from 1% decrease in interest rate |
|
$ |
5,102 |
|
|
$ |
3,003 |
|
Interest rate swaps: |
|
|
|
|
|
|
|
|
Notional amount |
|
$ |
150,000 |
|
|
$ |
150,000 |
|
Carrying amount and fair value |
|
$ |
(10,352 |
) |
|
$ |
(12,724 |
) |
Change in fair value from 1% increase in interest rate |
|
$ |
2,471 |
|
|
$ |
3,322 |
|
Change in fair value from 1% decrease in interest rate |
|
$ |
(2,516 |
) |
|
$ |
(3,401 |
) |
Foreign currency forward contracts: |
|
|
|
|
|
|
|
|
Notional amount |
|
$ |
190,205 |
|
|
$ |
156,840 |
|
Carrying amount and fair value |
|
$ |
(694 |
) |
|
$ |
(96 |
) |
Change in fair value from 10% appreciation of U.S. dollar |
|
$ |
2,786 |
|
|
$ |
2,523 |
|
Change in fair value from 10% depreciation of U.S. dollar |
|
$ |
(3,405 |
) |
|
$ |
(3,084 |
) |
Raw material commodity swaps: |
|
|
|
|
|
|
|
|
Notional amount (in metric tons of base metals) |
|
|
75 |
|
|
|
330 |
|
Carrying amount and fair value |
|
$ |
42 |
|
|
$ |
(576 |
) |
Change in fair value from 10% change in forward prices |
|
$ |
15 |
|
|
$ |
71 |
|
Precious metals forward contracts: |
|
|
|
|
|
|
|
|
Notional amount (in troy ounces) |
|
|
|
|
|
|
129 |
|
Carrying amount and fair value |
|
$ |
|
|
|
$ |
8 |
|
Change in fair value from 10% change in forward prices |
|
$ |
|
|
|
$ |
11 |
|
43
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Ferro is committed to maintaining disclosure controls and procedures that are designed to
ensure that information required to be disclosed in its Exchange Act reports is recorded,
processed, summarized, and reported within the time periods specified in the U.S. Securities and
Exchange Commissions rules and forms, and that such information is accumulated and communicated to
its management, including its Chief Executive Officer and Chief Financial Officer, as appropriate
to allow timely decisions regarding required disclosure.
As required by Rule 13a-15(b) of the Exchange Act, Ferro has carried out an evaluation, under
the supervision and with the participation of its management, including its Chief Executive Officer
and the Chief Financial Officer, of the effectiveness of the design and operation of its disclosure
controls and procedures. The evaluation examined those disclosure controls and procedures as of
September 30, 2009, the end of the period covered by this report. Based on that evaluation,
management concluded that the disclosure controls and procedures were effective as of September 30,
2009.
Changes in Internal Control over Financial Reporting
During the third quarter of 2009, there were no changes in our internal controls or in other
factors that materially affected, or are reasonably likely to materially affect, our internal
controls over financial reporting.
44
PART II OTHER INFORMATION
Item 1. Legal Proceedings
As previously disclosed, in February 2003, the Company produced documents in connection with
an investigation by the United States Department of Justice into possible antitrust violations in
the plastics additives industry. In April 2006, the Company was notified by the Department of
Justice that the Government had closed its investigation. Before closing its investigation, the
Department of Justice took no action against the Company or any of its current or former employees.
On March 28, 2003, the Company was named as a defendant in a direct purchaser class action
lawsuit seeking monetary damages and injunctive relief from alleged violations of the antitrust
laws by the Company and others participating in the plastics additives industry (In Re Plastics
Additives Antitrust Litigation, Gitto/Global Corporation v. Rohm & Haas Company, et al., Case No.
2:03-CV-2038-LDD, MDL No. 1684, U.S. District Court, Eastern
District of Pennsylvania). On December 28, 2004, PolyOne
Corporation also filed a lawsuit against the Company relating to alleged violations of the
antitrust laws by the Company and others participating in the plastics additives industry (PolyOne
Corp. v. Akzo Nobel N.V., et al., Case No. 2:05-MD-01684-LDD, MDL No. 1684, U.S. District Court,
Eastern District of Pennsylvania).
On
August 4, 2005, the Company further was named in an indirect purchaser class action lawsuit seeking monetary
damages and injunctive relief from alleged violations of the antitrust laws by the Company and
others participating in the plastics additives industry relating to alleged antitrust issues in the
plastics additives industry (In Re Indirect Purchaser, Plastic Additives Litigation, D.R. Ward
Construction, et al., v. Rohm & Haas Company, et al., Case No. 2:05-CV-04157-LDD, MDL No. 1684,
U.S. District Court, Eastern District of Pennsylvania). On May 6, 2004, the Company was named in
another indirect purchaser class action in California (Competition Collision Center, LLC v.
Crompton Corporation, et al., Superior Court of the State of California for the City and County of
San Francisco, Case No. CGC-040431278). In June 2008, the Company was named in four more indirect
purchaser class action lawsuits. These cases and the Competition Collision cases all contain
allegations similar to those asserted in the previously-filed cases. The four additional indirect
purchaser cases have been transferred to the Eastern District of Pennsylvania (Defren v. Rohm &
Haas Company, et al., Case No. 2:08-CV-03702-LDD (filed
June 12, 2008); Zebrowski v. Rohm & Haas Company, et al., Case
No. 2:08-CV-04161-LDD (filed June 23, 2008); Burg v. Rohm
& Haas Company, et al., Case No. 2:08-CV-04162-LDD (filed
June 30, 2008); Miller v.
Rohm & Haas Company, et al., Case
No. 2:08-CV-03701-LDD (filed June 18, 2008)). These four additional cases are brought
on behalf of alleged classes of indirect purchasers in Massachusetts, Minnesota, the District of
Columbia, and Florida.
In July 2007, the Company entered into written settlement agreements with the direct purchaser
class in the In Re Plastics Additives Antitrust Litigation and with PolyOne. Those cases are now
dismissed as to the Company, and the settlement of the direct purchaser class action was approved
by the U.S. District Court, Eastern District of Pennsylvania, in December 2007. Although the
Company decided to bring these two matters to a close through settlement, the Company did not admit
to any of the alleged violations and continues to deny any wrongdoing.
The Company intends to vigorously defend the remaining six civil actions alleging antitrust
violations in the plastics additives industry. The indirect purchaser action is currently stayed
pending a decision on class certification in the In Re Plastics Additives Antitrust Litigation.
The indirect purchaser cases are all in their early stages; therefore, the Company cannot determine
the outcome of these lawsuits at this time.
On December 22, 2006, the Company filed a lawsuit against the prior owner of certain (but not
all) assets, including its plastics additives business, acquired by the Company, seeking
indemnification for the defense of the above lawsuits and any resulting payments by the Company
(Ferro v. Cookson Group, et al., U.S. District Court, Northern District of Ohio, Eastern Division,
Case No. 1:06CV3070). In April 2008, the U.S. District Court, Northern District of Ohio, dismissed
our lawsuit, and the Company has appealed the courts decision to the United States Court of
Appeals for the Sixth Circuit. The submission of the case is complete, and the parties are
awaiting a ruling from the Sixth Circuit.
As previously disclosed, for the year ended December 31, 2007, the Company submitted deviation
reports required by the Title V air emission permit issued under the New Jersey Air Pollution
Control Act (the Title V Air Permit), which contained numerous deviations from the standards
required by the Title V Air Permit at our South Plainfield, New Jersey, facility. The Company is
in the process of finalizing the negotiation of an administrative consent order and a compliance
schedule to settle these issues with the New Jersey Department of Environmental Protection
(NJDEP). The Company expects to enter into a settlement before the end of the year at a cost of
less than $500,000.
45
There are various other lawsuits and claims pending against the Company and its consolidated
subsidiaries. In our opinion, the ultimate liabilities, if any, will not materially affect the
consolidated financial position, results of operations, or cash flows of the Company.
Item 1A. Risk Factors
There were no material changes to the risk factors disclosed in the Companys Annual Report on
Form 10-K for the year ended December 31, 2008.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
As previously disclosed, our 2009 Amended Credit Facility effectively prohibits us from paying
dividends on our preferred and common stock beginning in the second quarter of 2009.
Item 3. Defaults Upon Senior Securities
As previously disclosed, our 2009 Amended Credit Facility effectively prohibits us from paying
dividends on our preferred and common stock beginning in the second quarter of 2009. Consequently,
we are currently in arrears in the payment of dividends on our Series A ESOP Convertible Preferred
Stock. As of the date of filing of this Form 10-Q, the total arrearage in payment of dividends on
the convertible preferred stock was $339,000.
Item 4. Submission of Matters to a Vote of Security Holders
Not applicable.
Item 5. Other Information
Not applicable.
Item 6. Exhibits
The exhibits listed in the attached Exhibit Index are the exhibits required by Item 601 of
Regulation S-K.
46
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
Date: October 26, 2009 |
FERRO CORPORATION
(Registrant)
|
|
|
/s/ James F. Kirsch
|
|
|
James F. Kirsch |
|
|
Chairman, President and Chief Executive Officer
(Principal Executive Officer) |
|
|
Date: October 26, 2009 |
|
|
|
/s/ Sallie B. Bailey
|
|
|
Sallie B. Bailey |
|
|
Vice President and Chief Financial Officer
(Principal Financial Officer) |
|
47
EXHIBIT INDEX
The following exhibits are filed with this report or are incorporated here by reference to a
prior filing in accordance with Rule 12b-32 under the Securities and Exchange Act of 1934.
Exhibit:
3 |
|
Articles of incorporation and by-laws |
3.1 |
|
Eleventh Amended Articles of Incorporation. (Reference is made to Exhibit 4.1 to Ferro
Corporations Registration Statement on Form S-3, filed March 5, 2008, which Exhibit is
incorporated here by reference.) |
3.2 |
|
Certificate of Amendment to the Eleventh Amended Articles of Incorporation of Ferro
Corporation filed with the Ohio Secretary of State on December 29, 1994. (Reference is made to
Exhibit 4.2 to Ferro Corporations Registration Statement on Form S-3, filed March 5, 2008,
which Exhibit is incorporated here by reference.) |
3.3 |
|
Certificate of Amendment to the Eleventh Amended Articles of Incorporation of Ferro
Corporation filed with the Ohio Secretary of State on June 23, 1998. (Reference is made to
Exhibit 4.3 to Ferro Corporations Registration Statement on Form S-3, filed March 5, 2008,
which Exhibit is incorporated here by reference.) |
3.4 |
|
Ferro Corporation Code of Regulations. (Reference is made to Exhibit 4.4 to Ferro
Corporations Registration Statement on Form S-3, filed March 5, 2008, which Exhibit is
incorporated here by reference.) |
4 |
|
Instruments defining rights of security holders, including indentures |
4.1 |
|
Senior Indenture, dated as of March 5, 2008, by and between Ferro Corporation and U.S. Bank
National Association. (Reference is made to Exhibit 4.5 to Ferro Corporations Registration
Statement on Form S-3, filed March 5, 2008, which Exhibit is incorporated here by reference.) |
4.2 |
|
First Supplemental Indenture, dated August 19, 2008, by and between Ferro Corporation and
U.S. Bank National Association (with Form of 6.50% Convertible Senior Note due 2013).
(Reference is made to Exhibit 4.2 to Ferro Corporations Current Report on Form 8-K, filed
August 19, 2008, which Exhibit is incorporated here by reference.) |
|
|
The Company agrees, upon request, to furnish to the U.S. Securities and Exchange Commission a
copy of any instrument authorizing long-term debt that does not authorize debt in excess of
10% of the total assets of the Company and its subsidiaries on a consolidated basis. |
10.1 |
|
Separation Agreement and Release between Ferro Corporation and Barry D. Russell (Reference is
made to Exhibit 10.1 to Ferro Corporations Current Report on Form 8-K, filed September 29,
2009, which Exhibit is incorporated here by reference.) |
31.1 |
|
Certification of Principal Executive Officer Pursuant to Rule 13a-14(a)/15d-14(a). |
|
31.2 |
|
Certification of Principal Financial Officer Pursuant to Rule 13a-14(a)/15d-14(a). |
|
32.1 |
|
Certification of Principal Executive Officer Pursuant to 18 U.S.C. 1350. |
|
32.2 |
|
Certification of Principal Financial Officer Pursuant to 18 U.S.C. 1350. |
48